LT4855B - Pakeisti 4-amino-tiazol-2-il junginiai kaip nuo ciklino priklausomų kinazių inhibitoriai - Google Patents

Pakeisti 4-amino-tiazol-2-il junginiai kaip nuo ciklino priklausomų kinazių inhibitoriai Download PDF

Info

Publication number: LT4855B
Authority: LT; Lithuania
Prior art keywords: group; fused; compound; amino; nmr
Prior art date: 1997-10-27

Application number

LT2000033A

Other languages

English (en)

Lithuanian (lt)

Other versions

LT2000033A (en

Inventor

Wesley K.M. Chong

Song Shao Chu

Rohit R. Duvadie

Lin Li

Wei Xiao

Yi Yang

Original Assignee

Agouron Pharmaceuticals,Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-27

Filing date

2000-04-14

Publication date

2001-11-26

2000-04-14 Application filed by Agouron Pharmaceuticals,Inc. filed Critical Agouron Pharmaceuticals,Inc.

2001-06-25 Publication of LT2000033A publication Critical patent/LT2000033A/xx

2001-11-26 Publication of LT4855B publication Critical patent/LT4855B/lt

Links

108091007914 CDKs Proteins 0.000 title abstract description 56
102000003903 Cyclin-dependent kinases Human genes 0.000 title abstract description 45
108090000266 Cyclin-dependent kinases Proteins 0.000 title abstract description 45
239000003112 inhibitor Substances 0.000 title description 15
QHHHLHCCVDMOJI-UHFFFAOYSA-N 1,3-thiazol-4-amine Chemical class NC1=CSC=N1 QHHHLHCCVDMOJI-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 claims abstract description 254
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 83
108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 claims abstract description 63
125000002950 monocyclic group Chemical group 0.000 claims abstract description 46
125000002837 carbocyclic group Chemical group 0.000 claims abstract description 42
150000003839 salts Chemical class 0.000 claims abstract description 42
125000000623 heterocyclic group Chemical group 0.000 claims abstract description 41
229940002612 prodrug Drugs 0.000 claims abstract description 25
239000000651 prodrug Substances 0.000 claims abstract description 25
239000002207 metabolite Substances 0.000 claims abstract description 24
125000001424 substituent group Chemical group 0.000 claims abstract description 24
125000003367 polycyclic group Chemical group 0.000 claims abstract description 21
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims abstract description 21
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 20
239000008194 pharmaceutical composition Substances 0.000 claims abstract description 20
XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims abstract description 17
229910052760 oxygen Inorganic materials 0.000 claims abstract description 17
125000001188 haloalkyl group Chemical group 0.000 claims abstract description 16
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 16
125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 15
125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims abstract description 15
125000003368 amide group Chemical group 0.000 claims abstract description 14
125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 14
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 13
239000001301 oxygen Substances 0.000 claims abstract description 13
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 13
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 12
125000003118 aryl group Chemical group 0.000 claims abstract description 11
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 11
150000003568 thioethers Chemical class 0.000 claims abstract description 10
229910052736 halogen Inorganic materials 0.000 claims abstract description 7
150000002367 halogens Chemical class 0.000 claims abstract description 6
125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 157
102000016736 Cyclin Human genes 0.000 claims description 98
108050006400 Cyclin Proteins 0.000 claims description 98
-1 C 1 -C 6 alkoxy Chemical group 0.000 claims description 84
102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 claims description 62
239000003795 chemical substances by application Substances 0.000 claims description 34
125000000217 alkyl group Chemical group 0.000 claims description 33
230000022983 regulation of cell cycle Effects 0.000 claims description 22
230000005764 inhibitory process Effects 0.000 claims description 21
125000003545 alkoxy group Chemical group 0.000 claims description 18
125000003396 thiol group Chemical class [H]S* 0.000 claims description 16
125000003172 aldehyde group Chemical group 0.000 claims description 14
125000004185 ester group Chemical group 0.000 claims description 14
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
125000003342 alkenyl group Chemical group 0.000 claims description 12
125000000304 alkynyl group Chemical group 0.000 claims description 12
125000000101 thioether group Chemical group 0.000 claims description 12
ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 11
125000001841 imino group Chemical group [H]N=* 0.000 claims description 11
125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims description 11
125000005843 halogen group Chemical group 0.000 claims description 10
239000003937 drug carrier Substances 0.000 claims description 7
125000003277 amino group Chemical group 0.000 claims description 6
208000035475 disorder Diseases 0.000 claims description 6
125000001544 thienyl group Chemical class 0.000 claims description 6
239000003814 drug Substances 0.000 claims description 5
125000000565 sulfonamide group Chemical group 0.000 claims description 5
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
201000010099 disease Diseases 0.000 claims description 4
230000001404 mediated effect Effects 0.000 claims description 4
125000003282 alkyl amino group Chemical group 0.000 claims description 2
125000004104 aryloxy group Chemical group 0.000 claims description 2
NXYSYWNLUDSSGZ-UHFFFAOYSA-N cyano-N-iminophosphonamidic acid Chemical compound C(#N)P(=O)(N=N)O NXYSYWNLUDSSGZ-UHFFFAOYSA-N 0.000 claims 2
125000003158 alcohol group Chemical group 0.000 claims 1
OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 claims 1
125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
238000004519 manufacturing process Methods 0.000 claims 1
108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 abstract description 53
102100036239 Cyclin-dependent kinase 2 Human genes 0.000 abstract description 53
238000000034 method Methods 0.000 abstract description 43
101710106279 Cyclin-dependent kinase 1 Proteins 0.000 abstract description 32
102100032857 Cyclin-dependent kinase 1 Human genes 0.000 abstract description 32
206010028980 Neoplasm Diseases 0.000 abstract description 18
230000002401 inhibitory effect Effects 0.000 abstract description 7
108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 abstract description 6
102100026804 Cyclin-dependent kinase 6 Human genes 0.000 abstract description 6
230000001225 therapeutic effect Effects 0.000 abstract description 5
150000003573 thiols Chemical class 0.000 abstract description 5
150000001299 aldehydes Chemical class 0.000 abstract description 3
150000002148 esters Chemical class 0.000 abstract description 3
150000002576 ketones Chemical class 0.000 abstract description 3
229940124530 sulfonamide Drugs 0.000 abstract description 3
150000003456 sulfonamides Chemical class 0.000 abstract description 3
230000000069 prophylactic effect Effects 0.000 abstract description 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 6
125000006727 (C1-C6) alkenyl group Chemical group 0.000 abstract 3
125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 3
125000006728 (C1-C6) alkynyl group Chemical group 0.000 abstract 3
150000002466 imines Chemical class 0.000 abstract 2
125000000394 phosphonato group Chemical group [O-]P([O-])(*)=O 0.000 abstract 2
229910000073 phosphorus hydride Inorganic materials 0.000 abstract 2
RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical class NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 abstract 1
102100036252 Cyclin-dependent kinase 4 Human genes 0.000 abstract 1
230000036210 malignancy Effects 0.000 abstract 1
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 210
239000007787 solid Substances 0.000 description 201
238000004458 analytical method Methods 0.000 description 175
239000000460 chlorine Substances 0.000 description 155
238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 139
239000000203 mixture Substances 0.000 description 77
239000000843 powder Substances 0.000 description 73
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 65
229910001868 water Inorganic materials 0.000 description 60
239000000243 solution Substances 0.000 description 57
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 53
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 46
229910052739 hydrogen Inorganic materials 0.000 description 45
239000003921 oil Substances 0.000 description 44
235000019198 oils Nutrition 0.000 description 44
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 42
239000012043 crude product Substances 0.000 description 32
239000011734 sodium Substances 0.000 description 31
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
210000004027 cell Anatomy 0.000 description 26
238000001953 recrystallisation Methods 0.000 description 26
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 25
239000012044 organic layer Substances 0.000 description 25
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
UZKLFNHMBFDXEN-UHFFFAOYSA-N 2-bromo-1-(2,6-difluorophenyl)ethanone Chemical compound FC1=CC=CC(F)=C1C(=O)CBr UZKLFNHMBFDXEN-UHFFFAOYSA-N 0.000 description 21
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 21
RAPGMEHFXAWYSY-UHFFFAOYSA-N 6-isothiocyanato-1h-benzimidazole Chemical compound S=C=NC1=CC=C2N=CNC2=C1 RAPGMEHFXAWYSY-UHFFFAOYSA-N 0.000 description 20
239000000725 suspension Substances 0.000 description 20
239000013078 crystal Substances 0.000 description 19
235000019439 ethyl acetate Nutrition 0.000 description 19
SGXUUCSRVVSMGK-UHFFFAOYSA-N 2-bromo-1-(2-nitrophenyl)ethanone Chemical compound [O-][N+](=O)C1=CC=CC=C1C(=O)CBr SGXUUCSRVVSMGK-UHFFFAOYSA-N 0.000 description 18
238000000746 purification Methods 0.000 description 18
230000022131 cell cycle Effects 0.000 description 17
229910052757 nitrogen Inorganic materials 0.000 description 17
IMDUFDNFSJWYQT-UHFFFAOYSA-N 4-isothiocyanatobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(N=C=S)C=C1 IMDUFDNFSJWYQT-UHFFFAOYSA-N 0.000 description 16
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 16
238000004440 column chromatography Methods 0.000 description 16
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
239000000706 filtrate Substances 0.000 description 15
229910004373 HOAc Inorganic materials 0.000 description 14
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 14
238000003556 assay Methods 0.000 description 14
239000000047 product Substances 0.000 description 14
OGKWFMJVYGPCMI-UHFFFAOYSA-N 1-(4-isothiocyanatophenyl)imidazole Chemical compound C1=CC(N=C=S)=CC=C1N1C=NC=C1 OGKWFMJVYGPCMI-UHFFFAOYSA-N 0.000 description 13
239000002244 precipitate Substances 0.000 description 13
230000002829 reductive effect Effects 0.000 description 13
DXXKATNBNNUIAW-UHFFFAOYSA-N 1-(4-isothiocyanatophenyl)-4-methylpiperazine Chemical compound C1CN(C)CCN1C1=CC=C(N=C=S)C=C1 DXXKATNBNNUIAW-UHFFFAOYSA-N 0.000 description 12
MOZNZNKHRXRLLF-UHFFFAOYSA-N 4-(4-methylpiperazin-1-yl)aniline Chemical compound C1CN(C)CCN1C1=CC=C(N)C=C1 MOZNZNKHRXRLLF-UHFFFAOYSA-N 0.000 description 12
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
230000000694 effects Effects 0.000 description 12
229920006395 saturated elastomer Polymers 0.000 description 12
TXUHKKKUXDGIET-UHFFFAOYSA-N 2-bromo-1-(2-iodophenyl)ethanone Chemical compound BrCC(=O)C1=CC=CC=C1I TXUHKKKUXDGIET-UHFFFAOYSA-N 0.000 description 11
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
201000011510 cancer Diseases 0.000 description 11
WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 10
YUTFYMWVGAJBOG-UHFFFAOYSA-N 2-bromo-1-(3-methylthiophen-2-yl)ethanone Chemical compound CC=1C=CSC=1C(=O)CBr YUTFYMWVGAJBOG-UHFFFAOYSA-N 0.000 description 10
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 10
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 10
229910052794 bromium Inorganic materials 0.000 description 10
238000003818 flash chromatography Methods 0.000 description 10
239000001257 hydrogen Substances 0.000 description 10
239000010410 layer Substances 0.000 description 10
239000000463 material Substances 0.000 description 10
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
108090000623 proteins and genes Proteins 0.000 description 10
125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 10
AXUXRZZYZBZQAR-UHFFFAOYSA-N 4-(4-isothiocyanatophenyl)morpholine Chemical compound C1=CC(N=C=S)=CC=C1N1CCOCC1 AXUXRZZYZBZQAR-UHFFFAOYSA-N 0.000 description 9
PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 9
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 9
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 9
239000006071 cream Substances 0.000 description 9
229910052763 palladium Inorganic materials 0.000 description 9
125000003386 piperidinyl group Chemical group 0.000 description 9
239000000758 substrate Substances 0.000 description 9
ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 9
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 8
108010068192 Cyclin A Proteins 0.000 description 8
102100025191 Cyclin-A2 Human genes 0.000 description 8
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 8
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 8
239000012298 atmosphere Substances 0.000 description 8
230000001276 controlling effect Effects 0.000 description 8
238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 8
OSPXFZJVGJTCQS-UHFFFAOYSA-N tert-butyl 4-(4-isothiocyanatophenyl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=C(N=C=S)C=C1 OSPXFZJVGJTCQS-UHFFFAOYSA-N 0.000 description 8
ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 7
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 7
102000003910 Cyclin D Human genes 0.000 description 7
108090000259 Cyclin D Proteins 0.000 description 7
108090000257 Cyclin E Proteins 0.000 description 7
102000003909 Cyclin E Human genes 0.000 description 7
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 7
125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 7
239000012267 brine Substances 0.000 description 7
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
230000026731 phosphorylation Effects 0.000 description 7
238000006366 phosphorylation reaction Methods 0.000 description 7
125000004076 pyridyl group Chemical group 0.000 description 7
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 7
239000002904 solvent Substances 0.000 description 7
VMSZFBSYWXMXRF-UHFFFAOYSA-N 3-isothiocyanatopyridine Chemical compound S=C=NC1=CC=CN=C1 VMSZFBSYWXMXRF-UHFFFAOYSA-N 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
239000004480 active ingredient Substances 0.000 description 6
239000003054 catalyst Substances 0.000 description 6
125000000592 heterocycloalkyl group Chemical group 0.000 description 6
QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 6
VWOJSRICSKDKAW-UHFFFAOYSA-N 1-(4-nitrophenyl)piperazine Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CCNCC1 VWOJSRICSKDKAW-UHFFFAOYSA-N 0.000 description 5
KDTVMNGHHHHLSC-UHFFFAOYSA-N 2-bromo-1-(2,5-dimethylthiophen-3-yl)ethanone Chemical compound CC1=CC(C(=O)CBr)=C(C)S1 KDTVMNGHHHHLSC-UHFFFAOYSA-N 0.000 description 5
TWZKNPCXINHGGZ-UHFFFAOYSA-N 2-bromo-1-(2,6-dichlorophenyl)ethanone Chemical compound ClC1=CC=CC(Cl)=C1C(=O)CBr TWZKNPCXINHGGZ-UHFFFAOYSA-N 0.000 description 5
JEOVSZUEMCUDSC-UHFFFAOYSA-N 4-isothiocyanatobenzamide Chemical compound NC(=O)C1=CC=C(N=C=S)C=C1 JEOVSZUEMCUDSC-UHFFFAOYSA-N 0.000 description 5
XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 5
108091000080 Phosphotransferase Proteins 0.000 description 5
108050002653 Retinoblastoma protein Proteins 0.000 description 5
239000002253 acid Substances 0.000 description 5
229910052799 carbon Inorganic materials 0.000 description 5
238000004587 chromatography analysis Methods 0.000 description 5
UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 5
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
239000007789 gas Substances 0.000 description 5
102000020233 phosphotransferase Human genes 0.000 description 5
235000015320 potassium carbonate Nutrition 0.000 description 5
229910000027 potassium carbonate Inorganic materials 0.000 description 5
230000035755 proliferation Effects 0.000 description 5
235000018102 proteins Nutrition 0.000 description 5
102000004169 proteins and genes Human genes 0.000 description 5
125000003226 pyrazolyl group Chemical group 0.000 description 5
NIKPVOCZEJNWNE-LLVKDONJSA-N (2r)-4-(4-isothiocyanatophenyl)-1,2-dimethylpiperazine Chemical compound C1CN(C)[C@H](C)CN1C1=CC=C(N=C=S)C=C1 NIKPVOCZEJNWNE-LLVKDONJSA-N 0.000 description 4
JZKBLJVCWJDFTD-UHFFFAOYSA-N 1-[4-(4-isothiocyanatophenyl)piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C1=CC=C(N=C=S)C=C1 JZKBLJVCWJDFTD-UHFFFAOYSA-N 0.000 description 4
GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
GSCCVWPVPFIRJP-UHFFFAOYSA-N 2-bromo-1-(2,4-dimethylphenyl)ethanone Chemical compound CC1=CC=C(C(=O)CBr)C(C)=C1 GSCCVWPVPFIRJP-UHFFFAOYSA-N 0.000 description 4
DJZWWOHLQVQGOS-UHFFFAOYSA-N 2-bromo-1-(3,5-dichloropyridin-4-yl)ethanone Chemical compound ClC1=CN=CC(Cl)=C1C(=O)CBr DJZWWOHLQVQGOS-UHFFFAOYSA-N 0.000 description 4
OSGQJCPQPJDICN-UHFFFAOYSA-N 2-bromo-1-(3-methyl-5-nitrothiophen-2-yl)ethanone Chemical compound CC=1C=C([N+]([O-])=O)SC=1C(=O)CBr OSGQJCPQPJDICN-UHFFFAOYSA-N 0.000 description 4
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
102000006313 Cyclin D3 Human genes 0.000 description 4
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
241000238631 Hexapoda Species 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
229910052801 chlorine Inorganic materials 0.000 description 4
QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 4
229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 description 4
239000003480 eluent Substances 0.000 description 4
239000000284 extract Substances 0.000 description 4
229910052731 fluorine Inorganic materials 0.000 description 4
239000006260 foam Substances 0.000 description 4
239000000499 gel Substances 0.000 description 4
230000012010 growth Effects 0.000 description 4
239000012528 membrane Substances 0.000 description 4
238000001556 precipitation Methods 0.000 description 4
238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 4
ZEWLQHIMDGJCMD-UHFFFAOYSA-N tert-butyl 4-[4-[[4-amino-5-(2,4,6-trichlorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC(Cl)=CC=2Cl)Cl)S1 ZEWLQHIMDGJCMD-UHFFFAOYSA-N 0.000 description 4
ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 4
VGIIILXIQLXVLC-UHFFFAOYSA-N 1-(2,6-difluorophenyl)ethanone Chemical compound CC(=O)C1=C(F)C=CC=C1F VGIIILXIQLXVLC-UHFFFAOYSA-N 0.000 description 3
SUGXZLKUDLDTKX-UHFFFAOYSA-N 1-(2-nitrophenyl)ethanone Chemical compound CC(=O)C1=CC=CC=C1[N+]([O-])=O SUGXZLKUDLDTKX-UHFFFAOYSA-N 0.000 description 3
LDDDJTNSPCOVJA-UHFFFAOYSA-N 1-(3-amino-2,6-dichlorophenyl)ethanone Chemical compound CC(=O)C1=C(Cl)C=CC(N)=C1Cl LDDDJTNSPCOVJA-UHFFFAOYSA-N 0.000 description 3
VRPQCVLBOZOYCG-UHFFFAOYSA-N 1-isothiocyanato-4-methoxybenzene Chemical compound COC1=CC=C(N=C=S)C=C1 VRPQCVLBOZOYCG-UHFFFAOYSA-N 0.000 description 3
NXHSSIGRWJENBH-UHFFFAOYSA-N 1-isothiocyanato-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(N=C=S)C=C1 NXHSSIGRWJENBH-UHFFFAOYSA-N 0.000 description 3
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
NDRNGEZMYNKZQY-UHFFFAOYSA-N 2-bromo-1-(2,4,6-trichlorophenyl)ethanone Chemical compound ClC1=CC(Cl)=C(C(=O)CBr)C(Cl)=C1 NDRNGEZMYNKZQY-UHFFFAOYSA-N 0.000 description 3
LERVFZDJTYMIBL-UHFFFAOYSA-N 2-bromo-1-(2,6-dichloro-3-nitrophenyl)ethanone Chemical compound [O-][N+](=O)C1=CC=C(Cl)C(C(=O)CBr)=C1Cl LERVFZDJTYMIBL-UHFFFAOYSA-N 0.000 description 3
GKNCPTLOPRDYMH-UHFFFAOYSA-N 2-bromo-1-(2-methoxyphenyl)ethanone Chemical compound COC1=CC=CC=C1C(=O)CBr GKNCPTLOPRDYMH-UHFFFAOYSA-N 0.000 description 3
NSSRUVVGGMUREH-UHFFFAOYSA-N 2-bromo-1-(2-methyl-6-phenylphenyl)ethanone Chemical group CC1=CC=CC(C=2C=CC=CC=2)=C1C(=O)CBr NSSRUVVGGMUREH-UHFFFAOYSA-N 0.000 description 3
XQJAHBHCLXUGEP-UHFFFAOYSA-N 2-bromo-1-(4-methoxyphenyl)ethanone Chemical compound COC1=CC=C(C(=O)CBr)C=C1 XQJAHBHCLXUGEP-UHFFFAOYSA-N 0.000 description 3
MBUPVGIGAMCMBT-UHFFFAOYSA-N 2-bromo-1-(4-nitrophenyl)ethanone Chemical compound [O-][N+](=O)C1=CC=C(C(=O)CBr)C=C1 MBUPVGIGAMCMBT-UHFFFAOYSA-N 0.000 description 3
MSMAFPRJZLLQNJ-UHFFFAOYSA-N 2-bromo-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]ethanone Chemical compound FC(F)(F)C1=CC(Cl)=C(C(=O)CBr)C(Cl)=C1 MSMAFPRJZLLQNJ-UHFFFAOYSA-N 0.000 description 3
DMNJIOWQNVZGTK-UHFFFAOYSA-N 2-bromo-1-[2-fluoro-6-(trifluoromethyl)phenyl]ethanone Chemical compound FC1=CC=CC(C(F)(F)F)=C1C(=O)CBr DMNJIOWQNVZGTK-UHFFFAOYSA-N 0.000 description 3
XJZGRBZMXHGFCB-UHFFFAOYSA-N 4-(4-nitrophenyl)piperazin-2-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CC(=O)NCC1 XJZGRBZMXHGFCB-UHFFFAOYSA-N 0.000 description 3
OISQSDKFWKJEBA-UHFFFAOYSA-N 4-amino-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(N)C=C1 OISQSDKFWKJEBA-UHFFFAOYSA-N 0.000 description 3
HRDJPEMAGYHSJR-UHFFFAOYSA-N 4-isothiocyanato-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(N=C=S)C=C1 HRDJPEMAGYHSJR-UHFFFAOYSA-N 0.000 description 3
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
101150012716 CDK1 gene Proteins 0.000 description 3
108010058546 Cyclin D1 Proteins 0.000 description 3
108010058545 Cyclin D3 Proteins 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
101100059559 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) nimX gene Proteins 0.000 description 3
102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 3
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
239000000020 Nitrocellulose Substances 0.000 description 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
102400001093 PAK-2p27 Human genes 0.000 description 3
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
230000018199 S phase Effects 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
101100273808 Xenopus laevis cdk1-b gene Proteins 0.000 description 3
BIIVYFLTOXDAOV-YVEFUNNKSA-N alvocidib Chemical compound O[C@@H]1CN(C)CC[C@@H]1C1=C(O)C=C(O)C2=C1OC(C=1C(=CC=CC=1)Cl)=CC2=O BIIVYFLTOXDAOV-YVEFUNNKSA-N 0.000 description 3
229950010817 alvocidib Drugs 0.000 description 3
230000008901 benefit Effects 0.000 description 3
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 3
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 3
JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 3
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
238000009835 boiling Methods 0.000 description 3
239000002775 capsule Substances 0.000 description 3
238000010531 catalytic reduction reaction Methods 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 3
239000012971 dimethylpiperazine Substances 0.000 description 3
229960001484 edetic acid Drugs 0.000 description 3
238000010828 elution Methods 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
239000012634 fragment Substances 0.000 description 3
125000002541 furyl group Chemical group 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
125000002883 imidazolyl group Chemical group 0.000 description 3
125000001041 indolyl group Chemical group 0.000 description 3
125000000842 isoxazolyl group Chemical group 0.000 description 3
239000002609 medium Substances 0.000 description 3
WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 description 3
YACLXJDAXAGGMY-UHFFFAOYSA-N n'-(4-isothiocyanatophenyl)-n,n,n'-trimethylethane-1,2-diamine Chemical compound CN(C)CCN(C)C1=CC=C(N=C=S)C=C1 YACLXJDAXAGGMY-UHFFFAOYSA-N 0.000 description 3
RMMRFOKTUNHPBY-UHFFFAOYSA-N n-(3-acetyl-2,4-dichlorophenyl)acetamide Chemical compound CC(=O)NC1=CC=C(Cl)C(C(C)=O)=C1Cl RMMRFOKTUNHPBY-UHFFFAOYSA-N 0.000 description 3
125000001624 naphthyl group Chemical group 0.000 description 3
229920001220 nitrocellulos Polymers 0.000 description 3
125000002971 oxazolyl group Chemical group 0.000 description 3
125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 3
229940117953 phenylisothiocyanate Drugs 0.000 description 3
229910052698 phosphorus Inorganic materials 0.000 description 3
239000011574 phosphorus Substances 0.000 description 3
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
125000003373 pyrazinyl group Chemical group 0.000 description 3
125000000714 pyrimidinyl group Chemical group 0.000 description 3
125000000719 pyrrolidinyl group Chemical group 0.000 description 3
125000000168 pyrrolyl group Chemical group 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
238000010992 reflux Methods 0.000 description 3
239000000741 silica gel Substances 0.000 description 3
229910002027 silica gel Inorganic materials 0.000 description 3
239000002002 slurry Substances 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 3
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
238000012360 testing method Methods 0.000 description 3
125000003831 tetrazolyl group Chemical group 0.000 description 3
125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 description 3
125000000335 thiazolyl group Chemical group 0.000 description 3
230000007704 transition Effects 0.000 description 3
125000001425 triazolyl group Chemical group 0.000 description 3
241000701447 unidentified baculovirus Species 0.000 description 3
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
LHVNLXVOVGXVQC-SNVBAGLBSA-N (2r)-1,2-dimethyl-4-(4-nitrophenyl)piperazine Chemical compound C1CN(C)[C@H](C)CN1C1=CC=C([N+]([O-])=O)C=C1 LHVNLXVOVGXVQC-SNVBAGLBSA-N 0.000 description 2
UBLZWKCJZSDBGQ-AOOOYVTPSA-N (3r,5s)-3,5-dimethyl-1-(4-nitrophenyl)piperazine Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=CC=C([N+]([O-])=O)C=C1 UBLZWKCJZSDBGQ-AOOOYVTPSA-N 0.000 description 2
ACIOMPFLDCPKIS-UHFFFAOYSA-N (4-amino-2-anilino-1,3-thiazol-5-yl)-(3-nitrophenyl)methanone Chemical compound S1C(C(=O)C=2C=C(C=CC=2)[N+]([O-])=O)=C(N)N=C1NC1=CC=CC=C1 ACIOMPFLDCPKIS-UHFFFAOYSA-N 0.000 description 2
MJWMSFLDPWTOSC-UHFFFAOYSA-N 1,5-dimethylimidazole-4-carboxylic acid Chemical compound CC1=C(C(O)=O)N=CN1C MJWMSFLDPWTOSC-UHFFFAOYSA-N 0.000 description 2
XMHNCQLMSVKHEH-UHFFFAOYSA-N 1-(1,5-dimethylimidazol-4-yl)ethanone Chemical compound CC(=O)C=1N=CN(C)C=1C XMHNCQLMSVKHEH-UHFFFAOYSA-N 0.000 description 2
NAMVLFOWONWZFY-UHFFFAOYSA-N 1-(2,6-dichloro-3-nitrophenyl)ethanone Chemical compound CC(=O)C1=C(Cl)C=CC([N+]([O-])=O)=C1Cl NAMVLFOWONWZFY-UHFFFAOYSA-N 0.000 description 2
HYBDSXBLGCQKRE-UHFFFAOYSA-N 1-(2,6-dichlorophenyl)ethanone Chemical compound CC(=O)C1=C(Cl)C=CC=C1Cl HYBDSXBLGCQKRE-UHFFFAOYSA-N 0.000 description 2
NVGLKPGDXZAVGJ-UHFFFAOYSA-N 1-(2-bromo-6-methylphenyl)ethanone Chemical compound CC(=O)C1=C(C)C=CC=C1Br NVGLKPGDXZAVGJ-UHFFFAOYSA-N 0.000 description 2
XDXCBCXNCQGZPG-UHFFFAOYSA-N 1-(2-iodophenyl)ethanone Chemical compound CC(=O)C1=CC=CC=C1I XDXCBCXNCQGZPG-UHFFFAOYSA-N 0.000 description 2
OKABSSBMRAWDFQ-UHFFFAOYSA-N 1-(2-methyl-6-nitrophenyl)ethanone Chemical compound CC(=O)C1=C(C)C=CC=C1[N+]([O-])=O OKABSSBMRAWDFQ-UHFFFAOYSA-N 0.000 description 2
BCBFCGOOSCCPML-UHFFFAOYSA-N 1-(2-methyl-6-phenylphenyl)ethanone Chemical compound CC(=O)C1=C(C)C=CC=C1C1=CC=CC=C1 BCBFCGOOSCCPML-UHFFFAOYSA-N 0.000 description 2
AQIZCMXSOXEJKV-UHFFFAOYSA-N 1-(3-amino-4-bromo-2,6-dichlorophenyl)-2-bromoethanone Chemical compound NC1=C(Br)C=C(Cl)C(C(=O)CBr)=C1Cl AQIZCMXSOXEJKV-UHFFFAOYSA-N 0.000 description 2
UQSDAOKGPYTBFE-UHFFFAOYSA-N 1-(3-amino-4-bromo-2,6-dichlorophenyl)ethanone Chemical compound CC(=O)C1=C(Cl)C=C(Br)C(N)=C1Cl UQSDAOKGPYTBFE-UHFFFAOYSA-N 0.000 description 2
LATHMARHTWDRRH-UHFFFAOYSA-N 1-(3-methyl-5-nitrothiophen-2-yl)ethanone Chemical compound CC(=O)C=1SC([N+]([O-])=O)=CC=1C LATHMARHTWDRRH-UHFFFAOYSA-N 0.000 description 2
VWOWSQPOKLEXKA-UHFFFAOYSA-N 1-(4-isothiocyanatophenyl)-4-methyl-1,4-diazepane Chemical compound C1CN(C)CCCN1C1=CC=C(N=C=S)C=C1 VWOWSQPOKLEXKA-UHFFFAOYSA-N 0.000 description 2
UTFZPHKKRPDRJO-UHFFFAOYSA-N 1-(4-isothiocyanatophenyl)-4-pyridin-2-ylpiperazine Chemical compound C1=CC(N=C=S)=CC=C1N1CCN(C=2N=CC=CC=2)CC1 UTFZPHKKRPDRJO-UHFFFAOYSA-N 0.000 description 2
MYNNVLPKJBEFBO-UHFFFAOYSA-N 1-(4-isothiocyanatophenyl)-4-pyridin-4-ylpiperazine Chemical compound C1=CC(N=C=S)=CC=C1N1CCN(C=2C=CN=CC=2)CC1 MYNNVLPKJBEFBO-UHFFFAOYSA-N 0.000 description 2
KAKXOESNHIUYJT-UHFFFAOYSA-N 1-(4-isothiocyanatophenyl)ethanone Chemical compound CC(=O)C1=CC=C(N=C=S)C=C1 KAKXOESNHIUYJT-UHFFFAOYSA-N 0.000 description 2
HGDCEGHIUZDHIQ-UHFFFAOYSA-N 1-(4-nitrophenyl)-4-(2,2,2-trifluoroethyl)piperazine Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CCN(CC(F)(F)F)CC1 HGDCEGHIUZDHIQ-UHFFFAOYSA-N 0.000 description 2
PDPKKGUSHFEBDZ-UHFFFAOYSA-N 1-(4-nitrophenyl)-4-pyridin-4-ylpiperazine Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CCN(C=2C=CN=CC=2)CC1 PDPKKGUSHFEBDZ-UHFFFAOYSA-N 0.000 description 2
DJBGJOLGKNCUPH-UHFFFAOYSA-N 1-(cyclopropylmethyl)-4-(4-nitrophenyl)piperazine Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CCN(CC2CC2)CC1 DJBGJOLGKNCUPH-UHFFFAOYSA-N 0.000 description 2
PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 2
AFVUJJNEILZYJQ-UHFFFAOYSA-N 1-[4-(4-aminophenyl)-1-piperazinyl]ethanone Chemical compound C1CN(C(=O)C)CCN1C1=CC=C(N)C=C1 AFVUJJNEILZYJQ-UHFFFAOYSA-N 0.000 description 2
MRJJYUJULSZFDV-UHFFFAOYSA-N 1-chloro-4-(2-isothiocyanatoethyl)benzene Chemical compound ClC1=CC=C(CCN=C=S)C=C1 MRJJYUJULSZFDV-UHFFFAOYSA-N 0.000 description 2
ABQKHKWXTUVKGF-UHFFFAOYSA-N 1-isothiocyanato-4-methylbenzene Chemical compound CC1=CC=C(N=C=S)C=C1 ABQKHKWXTUVKGF-UHFFFAOYSA-N 0.000 description 2
XNADLAKKHYPORF-UHFFFAOYSA-N 1-methyl-4-(4-nitrophenyl)-1,4-diazepane Chemical compound C1CN(C)CCCN1C1=CC=C([N+]([O-])=O)C=C1 XNADLAKKHYPORF-UHFFFAOYSA-N 0.000 description 2
GBQPMUDVPGRNCX-UHFFFAOYSA-N 1-methyl-4-(4-nitrophenyl)piperazin-2-one Chemical compound C1C(=O)N(C)CCN1C1=CC=C([N+]([O-])=O)C=C1 GBQPMUDVPGRNCX-UHFFFAOYSA-N 0.000 description 2
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
CIMHDVRGGBXIRB-UHFFFAOYSA-N 2-(4-isothiocyanatophenyl)-1h-imidazole Chemical compound C1=CC(N=C=S)=CC=C1C1=NC=CN1 CIMHDVRGGBXIRB-UHFFFAOYSA-N 0.000 description 2
GJKIAPNNPWBCOF-UHFFFAOYSA-N 2-(4-nitrophenyl)-1h-imidazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=NC=CN1 GJKIAPNNPWBCOF-UHFFFAOYSA-N 0.000 description 2
PKVBZABQCCQHLD-UHFFFAOYSA-N 2-bromo-1-(2,4-dimethoxyphenyl)ethanone Chemical compound COC1=CC=C(C(=O)CBr)C(OC)=C1 PKVBZABQCCQHLD-UHFFFAOYSA-N 0.000 description 2
AFEAQWGXKZBGLW-UHFFFAOYSA-N 2-bromo-1-(2,5-dichlorothiophen-3-yl)ethanone Chemical compound ClC1=CC(C(=O)CBr)=C(Cl)S1 AFEAQWGXKZBGLW-UHFFFAOYSA-N 0.000 description 2
YSICJHNHYWMNBM-UHFFFAOYSA-N 2-bromo-1-(2,6-dimethylphenyl)ethanone Chemical compound CC1=CC=CC(C)=C1C(=O)CBr YSICJHNHYWMNBM-UHFFFAOYSA-N 0.000 description 2
AAYIDHHJOYBHPV-UHFFFAOYSA-N 2-bromo-1-(2-methyl-6-nitrophenyl)ethanone Chemical compound CC1=CC=CC([N+]([O-])=O)=C1C(=O)CBr AAYIDHHJOYBHPV-UHFFFAOYSA-N 0.000 description 2
VVFFORGXSNBBMF-UHFFFAOYSA-N 2-bromo-1-(3,4-dimethyl-2h-imidazol-4-yl)ethanone Chemical compound CN1CN=CC1(C)C(=O)CBr VVFFORGXSNBBMF-UHFFFAOYSA-N 0.000 description 2
VLASTNAYSUDRTA-UHFFFAOYSA-N 2-bromo-1-(3,5-dibromothiophen-2-yl)ethanone Chemical compound BrCC(=O)C=1SC(Br)=CC=1Br VLASTNAYSUDRTA-UHFFFAOYSA-N 0.000 description 2
BBLGULDFVZCLSR-UHFFFAOYSA-N 2-bromo-1-(3,5-dimethylpyridin-4-yl)ethanone;hydrobromide Chemical compound Br.CC1=CN=CC(C)=C1C(=O)CBr BBLGULDFVZCLSR-UHFFFAOYSA-N 0.000 description 2
PIQSJBQPXDKSHF-UHFFFAOYSA-N 2-bromo-1-(3-methyl-1-benzothiophen-2-yl)ethanone Chemical compound C1=CC=C2C(C)=C(C(=O)CBr)SC2=C1 PIQSJBQPXDKSHF-UHFFFAOYSA-N 0.000 description 2
ZGUAAHFGLUZMTG-UHFFFAOYSA-N 2-bromo-1-(4-methyl-1,3-thiazol-5-yl)ethanone Chemical compound CC=1N=CSC=1C(=O)CBr ZGUAAHFGLUZMTG-UHFFFAOYSA-N 0.000 description 2
NHZTZQDWMOWTJF-UHFFFAOYSA-N 2-bromo-1-(5-methyl-1h-imidazol-4-yl)ethanone Chemical compound CC=1N=CNC=1C(=O)CBr NHZTZQDWMOWTJF-UHFFFAOYSA-N 0.000 description 2
XSVXZERBVBHQFO-UHFFFAOYSA-N 2-chloro-1-(2,4,6-trifluorophenyl)ethanone Chemical compound FC1=CC(F)=C(C(=O)CCl)C(F)=C1 XSVXZERBVBHQFO-UHFFFAOYSA-N 0.000 description 2
VHBFEIBMZHEWSX-UHFFFAOYSA-N 2-isothiocyanatopropane Chemical compound CC(C)N=C=S VHBFEIBMZHEWSX-UHFFFAOYSA-N 0.000 description 2
LSMAJBKCYYJNCC-UHFFFAOYSA-N 3,3-dimethyl-1-(4-nitrophenyl)piperazine Chemical compound C1CNC(C)(C)CN1C1=CC=C([N+]([O-])=O)C=C1 LSMAJBKCYYJNCC-UHFFFAOYSA-N 0.000 description 2
JVGVDSSUAVXRDY-UHFFFAOYSA-N 3-(4-hydroxyphenyl)lactic acid Chemical compound OC(=O)C(O)CC1=CC=C(O)C=C1 JVGVDSSUAVXRDY-UHFFFAOYSA-N 0.000 description 2
VQFSKYLXGRUGCS-UHFFFAOYSA-N 3-(n-methyl-4-nitroanilino)propanenitrile Chemical compound N#CCCN(C)C1=CC=C([N+]([O-])=O)C=C1 VQFSKYLXGRUGCS-UHFFFAOYSA-N 0.000 description 2
GSBDHQDPAGRRJE-UHFFFAOYSA-N 4-(1h-imidazol-2-yl)aniline Chemical compound C1=CC(N)=CC=C1C1=NC=CN1 GSBDHQDPAGRRJE-UHFFFAOYSA-N 0.000 description 2
FBRZMCMDPQEDBX-UHFFFAOYSA-N 4-(4-aminophenyl)-1-methylpiperazin-2-one Chemical compound C1C(=O)N(C)CCN1C1=CC=C(N)C=C1 FBRZMCMDPQEDBX-UHFFFAOYSA-N 0.000 description 2
PZAWODZZVTUFBG-UHFFFAOYSA-N 4-(4-aminophenyl)piperazin-2-one Chemical compound C1=CC(N)=CC=C1N1CC(=O)NCC1 PZAWODZZVTUFBG-UHFFFAOYSA-N 0.000 description 2
URVDOOKVTSOJEB-UHFFFAOYSA-N 4-(4-aminophenyl)piperazine-1-carboxamide Chemical compound C1CN(C(=O)N)CCN1C1=CC=C(N)C=C1 URVDOOKVTSOJEB-UHFFFAOYSA-N 0.000 description 2
QCXZCUIFNOIEBW-UHFFFAOYSA-N 4-(4-isothiocyanatophenyl)-1-methylpiperazin-2-one Chemical compound C1C(=O)N(C)CCN1C1=CC=C(N=C=S)C=C1 QCXZCUIFNOIEBW-UHFFFAOYSA-N 0.000 description 2
BHENQKGTCSEDHD-UHFFFAOYSA-N 4-(4-isothiocyanatophenyl)piperazin-2-one Chemical compound C1CNC(=O)CN1C1=CC=C(N=C=S)C=C1 BHENQKGTCSEDHD-UHFFFAOYSA-N 0.000 description 2
ZULVJULBTWUAEV-UHFFFAOYSA-N 4-(4-isothiocyanatophenyl)pyridine Chemical compound C1=CC(N=C=S)=CC=C1C1=CC=NC=C1 ZULVJULBTWUAEV-UHFFFAOYSA-N 0.000 description 2
IZEFJGGUTYEWSF-UHFFFAOYSA-N 4-(4-isothiocyanatophenyl)thiomorpholine Chemical compound C1=CC(N=C=S)=CC=C1N1CCSCC1 IZEFJGGUTYEWSF-UHFFFAOYSA-N 0.000 description 2
FMLOSYIZNDLWOM-UHFFFAOYSA-N 4-(4-methyl-1,4-diazepan-1-yl)aniline Chemical compound C1CN(C)CCCN1C1=CC=C(N)C=C1 FMLOSYIZNDLWOM-UHFFFAOYSA-N 0.000 description 2
YEKKOBZSGMPECJ-UHFFFAOYSA-N 4-(4-methylpiperazin-1-yl)sulfonylaniline Chemical compound C1CN(C)CCN1S(=O)(=O)C1=CC=C(N)C=C1 YEKKOBZSGMPECJ-UHFFFAOYSA-N 0.000 description 2
NSUJRGALALTFBR-UHFFFAOYSA-N 4-(4-pyridin-2-ylpiperazin-1-yl)aniline Chemical compound C1=CC(N)=CC=C1N1CCN(C=2N=CC=CC=2)CC1 NSUJRGALALTFBR-UHFFFAOYSA-N 0.000 description 2
RJBAGSFWPCJRIT-UHFFFAOYSA-N 4-(4-pyridin-4-ylpiperazin-1-yl)aniline Chemical compound C1=CC(N)=CC=C1N1CCN(C=2C=CN=CC=2)CC1 RJBAGSFWPCJRIT-UHFFFAOYSA-N 0.000 description 2
DPBWFNDFMCCGGJ-UHFFFAOYSA-N 4-Piperidine carboxamide Chemical compound NC(=O)C1CCNCC1 DPBWFNDFMCCGGJ-UHFFFAOYSA-N 0.000 description 2
USTSWOLARJXUFU-UHFFFAOYSA-N 4-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]aniline Chemical compound C1=CC(N)=CC=C1N1CCN(CC(F)(F)F)CC1 USTSWOLARJXUFU-UHFFFAOYSA-N 0.000 description 2
XKRBQRAKPNGUGG-UHFFFAOYSA-N 4-[4-(cyclopropylmethyl)piperazin-1-yl]aniline Chemical compound C1=CC(N)=CC=C1N1CCN(CC2CC2)CC1 XKRBQRAKPNGUGG-UHFFFAOYSA-N 0.000 description 2
BABGMPQXLCJMSK-UHFFFAOYSA-N 4-amino-n,n-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(N)C=C1 BABGMPQXLCJMSK-UHFFFAOYSA-N 0.000 description 2
125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 2
BXIJUQJYXZCOFB-UHFFFAOYSA-N 4-n-[2-(dimethylamino)ethyl]-4-n-methylbenzene-1,4-diamine Chemical compound CN(C)CCN(C)C1=CC=C(N)C=C1 BXIJUQJYXZCOFB-UHFFFAOYSA-N 0.000 description 2
JXRGUPLJCCDGKG-UHFFFAOYSA-N 4-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=C(S(Cl)(=O)=O)C=C1 JXRGUPLJCCDGKG-UHFFFAOYSA-N 0.000 description 2
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
GOKQLNOWXHMQMX-UHFFFAOYSA-N C(#N)CCNCC1=CC=C(C=C1)N Chemical compound C(#N)CCNCC1=CC=C(C=C1)N GOKQLNOWXHMQMX-UHFFFAOYSA-N 0.000 description 2
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
229910021590 Copper(II) bromide Inorganic materials 0.000 description 2
108010068150 Cyclin B Proteins 0.000 description 2
102000002427 Cyclin B Human genes 0.000 description 2
102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 description 2
102100033233 Cyclin-dependent kinase inhibitor 1B Human genes 0.000 description 2
241000400611 Eucalyptus deanei Species 0.000 description 2
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
102000005720 Glutathione transferase Human genes 0.000 description 2
108010070675 Glutathione transferase Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
239000007995 HEPES buffer Substances 0.000 description 2
108010033040 Histones Proteins 0.000 description 2
101000715942 Homo sapiens Cyclin-dependent kinase 4 Proteins 0.000 description 2
GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 2
244000018764 Nyssa sylvatica Species 0.000 description 2
235000003339 Nyssa sylvatica Nutrition 0.000 description 2
235000019502 Orange oil Nutrition 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
201000000582 Retinoblastoma Diseases 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
102100033254 Tumor suppressor ARF Human genes 0.000 description 2
AFQBGSOUMOHWIQ-UHFFFAOYSA-N [4-amino-2-(4-nitroanilino)-1,3-thiazol-5-yl]-(2-hydroxyphenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2)O)=C(N)N=C1NC1=CC=C([N+]([O-])=O)C=C1 AFQBGSOUMOHWIQ-UHFFFAOYSA-N 0.000 description 2
CYNKHVCHLYBDDX-UHFFFAOYSA-N [4-amino-2-(4-piperazin-1-ylanilino)-1,3-thiazol-5-yl]-(2,4,6-trichlorophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC(Cl)=CC=2Cl)Cl)=C(N)N=C1NC(C=C1)=CC=C1N1CCNCC1 CYNKHVCHLYBDDX-UHFFFAOYSA-N 0.000 description 2
NWJYMCLPYVEZJW-UHFFFAOYSA-N [4-amino-2-(4-piperazin-1-ylanilino)-1,3-thiazol-5-yl]-(2,6-dichlorophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2Cl)Cl)=C(N)N=C1NC(C=C1)=CC=C1N1CCNCC1 NWJYMCLPYVEZJW-UHFFFAOYSA-N 0.000 description 2
229960000583 acetic acid Drugs 0.000 description 2
MNZMECMQTYGSOI-UHFFFAOYSA-N acetic acid;hydron;bromide Chemical compound Br.CC(O)=O MNZMECMQTYGSOI-UHFFFAOYSA-N 0.000 description 2
WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
239000012346 acetyl chloride Substances 0.000 description 2
230000004913 activation Effects 0.000 description 2
229910052784 alkaline earth metal Inorganic materials 0.000 description 2
239000000908 ammonium hydroxide Substances 0.000 description 2
239000000538 analytical sample Substances 0.000 description 2
230000001028 anti-proliverative effect Effects 0.000 description 2
239000002585 base Substances 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
HWKYQYACTJZGOI-UHFFFAOYSA-N benzyl 1-(4-aminophenyl)piperidine-4-carboxylate Chemical compound C1=CC(N)=CC=C1N1CCC(C(=O)OCC=2C=CC=CC=2)CC1 HWKYQYACTJZGOI-UHFFFAOYSA-N 0.000 description 2
JTCUWRLXLPKYNR-UHFFFAOYSA-N benzyl 1-(4-isothiocyanatophenyl)piperidine-4-carboxylate Chemical compound C1CN(C=2C=CC(=CC=2)N=C=S)CCC1C(=O)OCC1=CC=CC=C1 JTCUWRLXLPKYNR-UHFFFAOYSA-N 0.000 description 2
NWUVJPUNYKZVEL-UHFFFAOYSA-N benzyl 1-(4-nitrophenyl)piperidine-4-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CCC(C(=O)OCC=2C=CC=CC=2)CC1 NWUVJPUNYKZVEL-UHFFFAOYSA-N 0.000 description 2
YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
230000037396 body weight Effects 0.000 description 2
210000000481 breast Anatomy 0.000 description 2
229940045348 brown mixture Drugs 0.000 description 2
244000309464 bull Species 0.000 description 2
229910002091 carbon monoxide Inorganic materials 0.000 description 2
150000004649 carbonic acid derivatives Chemical class 0.000 description 2
230000003197 catalytic effect Effects 0.000 description 2
230000032823 cell division Effects 0.000 description 2
230000004663 cell proliferation Effects 0.000 description 2
125000001309 chloro group Chemical group Cl* 0.000 description 2
208000029742 colonic neoplasm Diseases 0.000 description 2
239000013058 crude material Substances 0.000 description 2
208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 2
125000004122 cyclic group Chemical group 0.000 description 2
230000037430 deletion Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
VDQVEACBQKUUSU-UHFFFAOYSA-M disodium;sulfanide Chemical compound [Na+].[Na+].[SH-] VDQVEACBQKUUSU-UHFFFAOYSA-M 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000001035 drying Methods 0.000 description 2
229950007919 egtazic acid Drugs 0.000 description 2
CRAIIIDNVLGIJA-UHFFFAOYSA-N ethyl 4-[4-amino-2-(4-sulfamoylanilino)-1,3-thiazole-5-carbonyl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1C(=O)C1=C(N)N=C(NC=2C=CC(=CC=2)S(N)(=O)=O)S1 CRAIIIDNVLGIJA-UHFFFAOYSA-N 0.000 description 2
MLOJHUCMCKBDLV-UHFFFAOYSA-N ethyl 4-isothiocyanatobenzoate Chemical compound CCOC(=O)C1=CC=C(N=C=S)C=C1 MLOJHUCMCKBDLV-UHFFFAOYSA-N 0.000 description 2
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
201000000497 familial melanoma Diseases 0.000 description 2
238000001914 filtration Methods 0.000 description 2
239000011737 fluorine Substances 0.000 description 2
238000009472 formulation Methods 0.000 description 2
230000002538 fungal effect Effects 0.000 description 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
102000048992 human CDK4 Human genes 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
238000002329 infrared spectrum Methods 0.000 description 2
150000007529 inorganic bases Chemical class 0.000 description 2
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
SRJOCJYGOFTFLH-UHFFFAOYSA-N isonipecotic acid Chemical compound OC(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-N 0.000 description 2
GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 2
108010052968 leupeptin Proteins 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
201000001441 melanoma Diseases 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
238000001471 micro-filtration Methods 0.000 description 2
150000007522 mineralic acids Chemical class 0.000 description 2
239000003226 mitogen Substances 0.000 description 2
230000011278 mitosis Effects 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
125000002757 morpholinyl group Chemical group 0.000 description 2
230000035772 mutation Effects 0.000 description 2
ZPGQFRCQCPDBIU-UHFFFAOYSA-N n,n,n'-trimethyl-n'-(4-nitrophenyl)propane-1,3-diamine Chemical compound CN(C)CCCN(C)C1=CC=C([N+]([O-])=O)C=C1 ZPGQFRCQCPDBIU-UHFFFAOYSA-N 0.000 description 2
PGWXUTHWTCRUAM-UHFFFAOYSA-N n,n-diethyl-4-isothiocyanatoaniline Chemical compound CCN(CC)C1=CC=C(N=C=S)C=C1 PGWXUTHWTCRUAM-UHFFFAOYSA-N 0.000 description 2
MAWMYYZJFUMOLA-UHFFFAOYSA-N n-[3-(2-bromoacetyl)-2,4-dichlorophenyl]acetamide Chemical compound CC(=O)NC1=CC=C(Cl)C(C(=O)CBr)=C1Cl MAWMYYZJFUMOLA-UHFFFAOYSA-N 0.000 description 2
IHIJFQRUYCEKCZ-UHFFFAOYSA-N n-methyl-4-nitrobenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1 IHIJFQRUYCEKCZ-UHFFFAOYSA-N 0.000 description 2
230000017095 negative regulation of cell growth Effects 0.000 description 2
238000006386 neutralization reaction Methods 0.000 description 2
125000006501 nitrophenyl group Chemical group 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
239000010502 orange oil Substances 0.000 description 2
150000007524 organic acids Chemical class 0.000 description 2
230000002018 overexpression Effects 0.000 description 2
CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
208000008443 pancreatic carcinoma Diseases 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
IMACFCSSMIZSPP-UHFFFAOYSA-N phenacyl chloride Chemical compound ClCC(=O)C1=CC=CC=C1 IMACFCSSMIZSPP-UHFFFAOYSA-N 0.000 description 2
HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
229940080469 phosphocellulose Drugs 0.000 description 2
125000004193 piperazinyl group Chemical group 0.000 description 2
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
229920000053 polysorbate 80 Polymers 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
238000012746 preparative thin layer chromatography Methods 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
230000002062 proliferating effect Effects 0.000 description 2
KRIOVPPHQSLHCZ-UHFFFAOYSA-N propiophenone Chemical compound CCC(=O)C1=CC=CC=C1 KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 description 2
125000002098 pyridazinyl group Chemical group 0.000 description 2
230000004044 response Effects 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
229910052979 sodium sulfide Inorganic materials 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
125000003107 substituted aryl group Chemical group 0.000 description 2
229910052717 sulfur Inorganic materials 0.000 description 2
ZLOWQQWAHOEBKP-UHFFFAOYSA-N tert-butyl 2,2-dimethyl-4-(4-nitrophenyl)piperazine-1-carboxylate Chemical compound C1C(C)(C)N(C(=O)OC(C)(C)C)CCN1C1=CC=C([N+]([O-])=O)C=C1 ZLOWQQWAHOEBKP-UHFFFAOYSA-N 0.000 description 2
UALUMNKWFROEDF-UHFFFAOYSA-N tert-butyl 2,6-dimethyl-4-(4-nitrophenyl)piperazine-1-carboxylate Chemical compound C1C(C)N(C(=O)OC(C)(C)C)C(C)CN1C1=CC=C([N+]([O-])=O)C=C1 UALUMNKWFROEDF-UHFFFAOYSA-N 0.000 description 2
QUKABSSPBMVPRN-UHFFFAOYSA-N tert-butyl 4-(4-aminophenyl)-2,2-dimethylpiperazine-1-carboxylate Chemical compound C1C(C)(C)N(C(=O)OC(C)(C)C)CCN1C1=CC=C(N)C=C1 QUKABSSPBMVPRN-UHFFFAOYSA-N 0.000 description 2
GSALRQQUCCLTEJ-UHFFFAOYSA-N tert-butyl 4-(4-aminophenyl)-2,6-dimethylpiperazine-1-carboxylate Chemical compound C1C(C)N(C(=O)OC(C)(C)C)C(C)CN1C1=CC=C(N)C=C1 GSALRQQUCCLTEJ-UHFFFAOYSA-N 0.000 description 2
NFMAYZVXNGHGEC-UHFFFAOYSA-N tert-butyl 4-(4-isothiocyanatophenyl)-2,2-dimethylpiperazine-1-carboxylate Chemical compound C1C(C)(C)N(C(=O)OC(C)(C)C)CCN1C1=CC=C(N=C=S)C=C1 NFMAYZVXNGHGEC-UHFFFAOYSA-N 0.000 description 2
MGYCIJUTYLUYJM-UHFFFAOYSA-N tert-butyl 4-(4-nitrophenyl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=C([N+]([O-])=O)C=C1 MGYCIJUTYLUYJM-UHFFFAOYSA-N 0.000 description 2
KLKBCNDBOVRQIJ-UHFFFAOYSA-N tert-butyl 4-(aminomethyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(CN)CC1 KLKBCNDBOVRQIJ-UHFFFAOYSA-N 0.000 description 2
FMEMRHLGNRGCIR-UHFFFAOYSA-N tert-butyl 4-[4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]-2,2-dimethylpiperazine-1-carboxylate Chemical compound C1C(C)(C)N(C(=O)OC(C)(C)C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 FMEMRHLGNRGCIR-UHFFFAOYSA-N 0.000 description 2
ZLDQWKGITVKCON-UHFFFAOYSA-N tert-butyl 4-[[(4-aminophenyl)sulfonylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CNS(=O)(=O)C1=CC=C(N)C=C1 ZLDQWKGITVKCON-UHFFFAOYSA-N 0.000 description 2
ZRNKLOPWVPWOQL-UHFFFAOYSA-N tert-butyl 4-[[(4-nitrophenyl)sulfonylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CNS(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1 ZRNKLOPWVPWOQL-UHFFFAOYSA-N 0.000 description 2
IMKURLSSEKFVNT-UHFFFAOYSA-N tert-butyl 4-[[[4-[(5-acetyl-4-amino-1,3-thiazol-2-yl)amino]phenyl]sulfonylamino]methyl]piperidine-1-carboxylate Chemical compound NC1=C(C(=O)C)SC(NC=2C=CC(=CC=2)S(=O)(=O)NCC2CCN(CC2)C(=O)OC(C)(C)C)=N1 IMKURLSSEKFVNT-UHFFFAOYSA-N 0.000 description 2
YHFUWPUJUMZXBD-UHFFFAOYSA-N tert-butyl 4-carbamoylpiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(C(N)=O)CC1 YHFUWPUJUMZXBD-UHFFFAOYSA-N 0.000 description 2
WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 2
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
GZNAASVAJNXPPW-UHFFFAOYSA-M tin(4+) chloride dihydrate Chemical compound O.O.[Cl-].[Sn+4] GZNAASVAJNXPPW-UHFFFAOYSA-M 0.000 description 2
FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Substances O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
239000003656 tris buffered saline Substances 0.000 description 2
IHIXIJGXTJIKRB-UHFFFAOYSA-N trisodium vanadate Chemical compound [Na+].[Na+].[Na+].[O-][V]([O-])([O-])=O IHIXIJGXTJIKRB-UHFFFAOYSA-N 0.000 description 2
210000004881 tumor cell Anatomy 0.000 description 2
KYBCNVWACWSAMB-UHFFFAOYSA-N (2,6-difluorophenyl)-[2-[4-(4-pyridin-4-ylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]methanone Chemical compound FC1=CC=CC(F)=C1C(=O)C(S1)=CN=C1NC1=CC=C(N2CCN(CC2)C=2C=CN=CC=2)C=C1 KYBCNVWACWSAMB-UHFFFAOYSA-N 0.000 description 1
JOMNTHCQHJPVAZ-RXMQYKEDSA-N (2r)-2-methylpiperazine Chemical compound C[C@@H]1CNCCN1 JOMNTHCQHJPVAZ-RXMQYKEDSA-N 0.000 description 1
IFNWESYYDINUHV-OLQVQODUSA-N (2s,6r)-2,6-dimethylpiperazine Chemical compound C[C@H]1CNC[C@@H](C)N1 IFNWESYYDINUHV-OLQVQODUSA-N 0.000 description 1
LIQPGGJWKGPLLI-UHFFFAOYSA-N (3-amino-2,6-dichlorophenyl)-[4-amino-2-(4-piperazin-1-ylanilino)-1,3-thiazol-5-yl]methanone trihydrochloride Chemical compound Cl.Cl.Cl.S1C(C(=O)C=2C(=C(N)C=CC=2Cl)Cl)=C(N)N=C1NC(C=C1)=CC=C1N1CCNCC1 LIQPGGJWKGPLLI-UHFFFAOYSA-N 0.000 description 1
YVMKMOMFEQIWAX-UHFFFAOYSA-N (3-amino-4-bromo-2,6-dichlorophenyl)-[4-amino-2-[4-(4-methylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]methanone Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=C(N)C(Br)=CC=2Cl)Cl)S1 YVMKMOMFEQIWAX-UHFFFAOYSA-N 0.000 description 1
MTKCOKFSICWGPP-UHFFFAOYSA-N (4-amino-2-anilino-1,3-thiazol-5-yl)-(3-aminophenyl)methanone Chemical compound S1C(C(=O)C=2C=C(N)C=CC=2)=C(N)N=C1NC1=CC=CC=C1 MTKCOKFSICWGPP-UHFFFAOYSA-N 0.000 description 1
JGCWBWPRMOVANG-UHFFFAOYSA-N (4-amino-2-anilino-1,3-thiazol-5-yl)-(4-aminophenyl)methanone Chemical compound S1C(C(=O)C=2C=CC(N)=CC=2)=C(N)N=C1NC1=CC=CC=C1 JGCWBWPRMOVANG-UHFFFAOYSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
RKOUFQLNMRAACI-UHFFFAOYSA-N 1,1,1-trifluoro-2-iodoethane Chemical compound FC(F)(F)CI RKOUFQLNMRAACI-UHFFFAOYSA-N 0.000 description 1
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
JXUKFFRPLNTYIV-UHFFFAOYSA-N 1,3,5-trifluorobenzene Chemical compound FC1=CC(F)=CC(F)=C1 JXUKFFRPLNTYIV-UHFFFAOYSA-N 0.000 description 1
AUSAFZNIOAOSTQ-UHFFFAOYSA-N 1-(2,4,6-trichlorophenyl)ethanone Chemical compound CC(=O)C1=C(Cl)C=C(Cl)C=C1Cl AUSAFZNIOAOSTQ-UHFFFAOYSA-N 0.000 description 1
XWCIICLTKWRWCI-UHFFFAOYSA-N 1-(2,4,6-trimethylphenyl)ethanone Chemical compound CC(=O)C1=C(C)C=C(C)C=C1C XWCIICLTKWRWCI-UHFFFAOYSA-N 0.000 description 1
GYFDNIRENHZKGR-UHFFFAOYSA-N 1-(2,5-dichlorothiophen-3-yl)ethanone Chemical compound CC(=O)C=1C=C(Cl)SC=1Cl GYFDNIRENHZKGR-UHFFFAOYSA-N 0.000 description 1
DDXBCZCBZGPSHD-UHFFFAOYSA-N 1-(2,6-dimethylphenyl)ethanone Chemical compound CC(=O)C1=C(C)C=CC=C1C DDXBCZCBZGPSHD-UHFFFAOYSA-N 0.000 description 1
JIZVGEJTLPEYLM-UHFFFAOYSA-N 1-(2-isothiocyanatoethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCN=C=S)C=C1 JIZVGEJTLPEYLM-UHFFFAOYSA-N 0.000 description 1
VWXIWFCXVFGRMY-UHFFFAOYSA-N 1-(3,5-dibromothiophen-2-yl)ethanone Chemical compound CC(=O)C=1SC(Br)=CC=1Br VWXIWFCXVFGRMY-UHFFFAOYSA-N 0.000 description 1
ZKJBKKNRSCBIPT-UHFFFAOYSA-N 1-(3,5-dimethylpyridin-4-yl)ethanone Chemical compound CC(=O)C1=C(C)C=NC=C1C ZKJBKKNRSCBIPT-UHFFFAOYSA-N 0.000 description 1
OQNQPCNGVIBXSP-UHFFFAOYSA-N 1-(4-isothiocyanatophenyl)-4-(2,2,2-trifluoroethyl)piperazine Chemical compound C1CN(CC(F)(F)F)CCN1C1=CC=C(N=C=S)C=C1 OQNQPCNGVIBXSP-UHFFFAOYSA-N 0.000 description 1
RCRSHXXGKQQHTL-UHFFFAOYSA-N 1-(4-isothiocyanatophenyl)sulfonyl-4-methylpiperazine Chemical compound C1CN(C)CCN1S(=O)(=O)C1=CC=C(N=C=S)C=C1 RCRSHXXGKQQHTL-UHFFFAOYSA-N 0.000 description 1
CUOTYNOZPMJLBX-UHFFFAOYSA-N 1-(4-nitrophenyl)-4-pyridin-2-ylpiperazine Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CCN(C=2N=CC=CC=2)CC1 CUOTYNOZPMJLBX-UHFFFAOYSA-N 0.000 description 1
ZIRBMAVPCZUDTF-UHFFFAOYSA-N 1-(4-nitrophenyl)piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=CC=C([N+]([O-])=O)C=C1 ZIRBMAVPCZUDTF-UHFFFAOYSA-N 0.000 description 1
ZBBBTXVKONJYGS-UHFFFAOYSA-N 1-(cyclopropylmethyl)-4-(4-isothiocyanatophenyl)piperazine Chemical compound C1=CC(N=C=S)=CC=C1N1CCN(CC2CC2)CC1 ZBBBTXVKONJYGS-UHFFFAOYSA-N 0.000 description 1
HUYOVUYNRGOCLZ-UHFFFAOYSA-N 1-(isothiocyanatomethyl)-2-methoxybenzene Chemical compound COC1=CC=CC=C1CN=C=S HUYOVUYNRGOCLZ-UHFFFAOYSA-N 0.000 description 1
IYMYYQMPOBPRPU-UHFFFAOYSA-N 1-[2-fluoro-6-(trifluoromethyl)phenyl]ethanone Chemical compound CC(=O)C1=C(F)C=CC=C1C(F)(F)F IYMYYQMPOBPRPU-UHFFFAOYSA-N 0.000 description 1
QUZMCJMGHMRZHA-UHFFFAOYSA-N 1-[4-(4-nitrophenyl)piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C1=CC=C([N+]([O-])=O)C=C1 QUZMCJMGHMRZHA-UHFFFAOYSA-N 0.000 description 1
VKZZLZIMGSAVMA-UHFFFAOYSA-N 1-[4-[4-[[4-amino-5-(2,5-dimethylthiophene-3-carbonyl)-1,3-thiazol-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C2=C(SC(C)=C2)C)S1 VKZZLZIMGSAVMA-UHFFFAOYSA-N 0.000 description 1
IEVHDEKPLWWGHK-UHFFFAOYSA-N 1-[4-[4-[[4-amino-5-(3-methylthiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C2=C(C=CS2)C)S1 IEVHDEKPLWWGHK-UHFFFAOYSA-N 0.000 description 1
KLIUTWWLRZSESY-UHFFFAOYSA-N 1-[4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]piperidine-4-carboxylic acid Chemical compound S1C(C(=O)C=2C(=CC=CC=2F)F)=C(N)N=C1NC(C=C1)=CC=C1N1CCC(C(O)=O)CC1 KLIUTWWLRZSESY-UHFFFAOYSA-N 0.000 description 1
OMDFNWOGKAFGIY-UHFFFAOYSA-N 1-[4-[[4-amino-5-(2-nitrobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)S1 OMDFNWOGKAFGIY-UHFFFAOYSA-N 0.000 description 1
LAYMTCGPRMLGBX-UHFFFAOYSA-N 1-[4-[[4-amino-5-(3-methylthiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1NC1=NC(N)=C(C(=O)C2=C(C=CS2)C)S1 LAYMTCGPRMLGBX-UHFFFAOYSA-N 0.000 description 1
SNLGBRZZFRSXHA-UHFFFAOYSA-N 1-iodo-4-isothiocyanatobenzene Chemical compound IC1=CC=C(N=C=S)C=C1 SNLGBRZZFRSXHA-UHFFFAOYSA-N 0.000 description 1
UKVFWFDXYBLOLU-UHFFFAOYSA-N 1-isothiocyanato-3-methoxypropane Chemical compound COCCCN=C=S UKVFWFDXYBLOLU-UHFFFAOYSA-N 0.000 description 1
OQXRBXAFSXVCCO-UHFFFAOYSA-N 1-isothiocyanato-4-phenylmethoxybenzene Chemical compound C1=CC(N=C=S)=CC=C1OCC1=CC=CC=C1 OQXRBXAFSXVCCO-UHFFFAOYSA-N 0.000 description 1
FXHRAKUEZPSMLJ-UHFFFAOYSA-N 1-methyl-1,4-diazepane Chemical compound CN1CCCNCC1 FXHRAKUEZPSMLJ-UHFFFAOYSA-N 0.000 description 1
GZNDUKANJZIZOT-UHFFFAOYSA-N 1-methyl-4-(4-nitrophenyl)piperazine Chemical compound C1CN(C)CCN1C1=CC=C([N+]([O-])=O)C=C1 GZNDUKANJZIZOT-UHFFFAOYSA-N 0.000 description 1
WXLNVAHDEMUAMA-UHFFFAOYSA-N 1-methyl-4-(4-nitrophenyl)sulfonylpiperazine Chemical compound C1CN(C)CCN1S(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1 WXLNVAHDEMUAMA-UHFFFAOYSA-N 0.000 description 1
OQZBAQXTXNIPRA-UHFFFAOYSA-N 1-pyridin-4-ylpiperazine Chemical compound C1CNCCN1C1=CC=NC=C1 OQZBAQXTXNIPRA-UHFFFAOYSA-N 0.000 description 1
CCXSGQZMYLXTOI-UHFFFAOYSA-N 13506-76-8 Chemical compound CC1=CC=CC([N+]([O-])=O)=C1C(O)=O CCXSGQZMYLXTOI-UHFFFAOYSA-N 0.000 description 1
HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
OAMHTTBNEJBIKA-UHFFFAOYSA-N 2,2,2-trichloro-1-phenylethanone Chemical compound ClC(Cl)(Cl)C(=O)C1=CC=CC=C1 OAMHTTBNEJBIKA-UHFFFAOYSA-N 0.000 description 1
CERJZAHSUZVMCH-UHFFFAOYSA-N 2,2-dichloro-1-phenylethanone Chemical compound ClC(Cl)C(=O)C1=CC=CC=C1 CERJZAHSUZVMCH-UHFFFAOYSA-N 0.000 description 1
LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
OLYKCPDTXVZOQF-UHFFFAOYSA-N 2,2-difluoro-1-phenylethanone Chemical compound FC(F)C(=O)C1=CC=CC=C1 OLYKCPDTXVZOQF-UHFFFAOYSA-N 0.000 description 1
PIPWSBOFSUJCCO-UHFFFAOYSA-N 2,2-dimethylpiperazine Chemical compound CC1(C)CNCCN1 PIPWSBOFSUJCCO-UHFFFAOYSA-N 0.000 description 1
OZGSEIVTQLXWRO-UHFFFAOYSA-N 2,4,6-trichlorobenzoyl chloride Chemical compound ClC(=O)C1=C(Cl)C=C(Cl)C=C1Cl OZGSEIVTQLXWRO-UHFFFAOYSA-N 0.000 description 1
CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
WAQFYSJKIRRXLP-UHFFFAOYSA-N 2,4-dibromothiophene Chemical compound BrC1=CSC(Br)=C1 WAQFYSJKIRRXLP-UHFFFAOYSA-N 0.000 description 1
HCBHQDKBSKYGCK-UHFFFAOYSA-N 2,6-dimethylbenzoic acid Chemical compound CC1=CC=CC(C)=C1C(O)=O HCBHQDKBSKYGCK-UHFFFAOYSA-N 0.000 description 1
DOJHXRHONGFBFT-BHGWPJFGSA-N 2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-n-[(e)-[1-[3-(trifluoromethyl)phenyl]pyrrol-2-yl]methylideneamino]acetamide Chemical compound CC1=CC(C)=NC(SCC(=O)N\N=C\C=2N(C=CC=2)C=2C=C(C=CC=2)C(F)(F)F)=N1 DOJHXRHONGFBFT-BHGWPJFGSA-N 0.000 description 1
GMOHPXQFJTVQPS-UHFFFAOYSA-N 2-(6-amino-3,5-dicyano-4-thiophen-2-ylpyridin-2-yl)sulfanyl-n-benzylacetamide Chemical compound N#CC=1C(C=2SC=CC=2)=C(C#N)C(N)=NC=1SCC(=O)NCC1=CC=CC=C1 GMOHPXQFJTVQPS-UHFFFAOYSA-N 0.000 description 1
XJBMXIDOMRAJNL-UHFFFAOYSA-N 2-[(6-nitro-1h-benzimidazol-2-yl)sulfanyl]-n-[3-(trifluoromethyl)phenyl]acetamide Chemical compound N1C2=CC([N+](=O)[O-])=CC=C2N=C1SCC(=O)NC1=CC=CC(C(F)(F)F)=C1 XJBMXIDOMRAJNL-UHFFFAOYSA-N 0.000 description 1
TVUBUUPBUCLYJZ-UHFFFAOYSA-N 2-[4-(2-bromoacetyl)phenyl]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1=CC=C(C(=O)CBr)C=C1 TVUBUUPBUCLYJZ-UHFFFAOYSA-N 0.000 description 1
NGYQEBIEZCFFTE-UHFFFAOYSA-N 2-[4-amino-2-(3-cyanoanilino)-1,3-thiazole-5-carbonyl]benzonitrile Chemical compound S1C(C(=O)C=2C(=CC=CC=2)C#N)=C(N)N=C1NC1=CC=CC(C#N)=C1 NGYQEBIEZCFFTE-UHFFFAOYSA-N 0.000 description 1
GEIMZZYVEJTRQB-UHFFFAOYSA-N 2-[4-amino-2-(4-methoxyanilino)-1,3-thiazole-5-carbonyl]benzonitrile Chemical compound C1=CC(OC)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2)C#N)S1 GEIMZZYVEJTRQB-UHFFFAOYSA-N 0.000 description 1
KDLXLUWGDVCILX-UHFFFAOYSA-N 2-bromo-1-(1,5-dimethylimidazol-4-yl)ethanone Chemical compound CC1=C(C(=O)CBr)N=CN1C KDLXLUWGDVCILX-UHFFFAOYSA-N 0.000 description 1
HCUDUMSINCWZFD-UHFFFAOYSA-N 2-bromo-1-(2,4,6-trifluorophenyl)ethanone Chemical compound FC1=CC(F)=C(C(=O)CBr)C(F)=C1 HCUDUMSINCWZFD-UHFFFAOYSA-N 0.000 description 1
HRAZXKYOYNRVMU-UHFFFAOYSA-N 2-bromo-1-(2,4,6-trimethylphenyl)ethanone Chemical compound CC1=CC(C)=C(C(=O)CBr)C(C)=C1 HRAZXKYOYNRVMU-UHFFFAOYSA-N 0.000 description 1
COYVUIGEBKDHDO-UHFFFAOYSA-N 2-bromo-1-(2-bromo-6-methylphenyl)ethanone Chemical compound CC1=CC=CC(Br)=C1C(=O)CBr COYVUIGEBKDHDO-UHFFFAOYSA-N 0.000 description 1
GZHPNIQBPGUSSX-UHFFFAOYSA-N 2-bromo-1-(3-nitrophenyl)ethanone Chemical compound [O-][N+](=O)C1=CC=CC(C(=O)CBr)=C1 GZHPNIQBPGUSSX-UHFFFAOYSA-N 0.000 description 1
VPUBAVYOQQLHPM-UHFFFAOYSA-N 2-bromo-1-(5-chloro-1-benzofuran-2-yl)ethanone Chemical compound ClC1=CC=C2OC(C(=O)CBr)=CC2=C1 VPUBAVYOQQLHPM-UHFFFAOYSA-N 0.000 description 1
YHXHHGDUANVQHE-UHFFFAOYSA-N 2-bromo-1-naphthalen-2-ylethanone Chemical compound C1=CC=CC2=CC(C(=O)CBr)=CC=C21 YHXHHGDUANVQHE-UHFFFAOYSA-N 0.000 description 1
DNPMOGQMEOPVNT-UHFFFAOYSA-N 2-bromo-1-pyridin-2-ylethanone Chemical compound BrCC(=O)C1=CC=CC=N1 DNPMOGQMEOPVNT-UHFFFAOYSA-N 0.000 description 1
ILEZTVGLBNABDK-UHFFFAOYSA-N 2-bromo-3-methyl-5-nitrothiophene Chemical compound CC=1C=C([N+]([O-])=O)SC=1Br ILEZTVGLBNABDK-UHFFFAOYSA-N 0.000 description 1
ICXBPDJQFPIBSS-UHFFFAOYSA-N 2-bromo-6-methylbenzoic acid Chemical compound CC1=CC=CC(Br)=C1C(O)=O ICXBPDJQFPIBSS-UHFFFAOYSA-N 0.000 description 1
125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 1
XOKIPANBKVPEEZ-UHFFFAOYSA-N 2-chloro-1-(1-methylpyrrol-2-yl)ethanone Chemical compound CN1C=CC=C1C(=O)CCl XOKIPANBKVPEEZ-UHFFFAOYSA-N 0.000 description 1
VYWPPRLJNVHPEU-UHFFFAOYSA-N 2-chloro-1-(2,4-dichlorophenyl)ethanone Chemical compound ClCC(=O)C1=CC=C(Cl)C=C1Cl VYWPPRLJNVHPEU-UHFFFAOYSA-N 0.000 description 1
125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
FNRMMDCDHWCQTH-UHFFFAOYSA-N 2-chloropyridine;3-chloropyridine;4-chloropyridine Chemical compound ClC1=CC=NC=C1.ClC1=CC=CN=C1.ClC1=CC=CC=N1 FNRMMDCDHWCQTH-UHFFFAOYSA-N 0.000 description 1
125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 1
125000003816 2-hydroxybenzoyl group Chemical group OC1=C(C(=O)*)C=CC=C1 0.000 description 1
SQIRBZKOKAEMNS-UHFFFAOYSA-N 2-isothiocyanato-n,n-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1N=C=S SQIRBZKOKAEMNS-UHFFFAOYSA-N 0.000 description 1
SIGIUGSFQGWMBF-UHFFFAOYSA-N 2-isothiocyanatobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1N=C=S SIGIUGSFQGWMBF-UHFFFAOYSA-N 0.000 description 1
YRNDGUSDBCARGC-UHFFFAOYSA-N 2-methoxyacetophenone Chemical compound COCC(=O)C1=CC=CC=C1 YRNDGUSDBCARGC-UHFFFAOYSA-N 0.000 description 1
LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 2-phenyl-1h-imidazole Chemical compound C1=CNC(C=2C=CC=CC=2)=N1 ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 0.000 description 1
125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
BUQPTOSHKHYHHB-UHFFFAOYSA-N 3,5-dichloropyridine-4-carboxylic acid Chemical compound OC(=O)C1=C(Cl)C=NC=C1Cl BUQPTOSHKHYHHB-UHFFFAOYSA-N 0.000 description 1
PUSJAEJRDNPYKM-UHFFFAOYSA-N 3-Acetyl-2,5-dimethylthiophene Chemical compound CC(=O)C=1C=C(C)SC=1C PUSJAEJRDNPYKM-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
UXCYPHCFQAFVFH-UHFFFAOYSA-N 3-isothiocyanatobenzonitrile Chemical compound S=C=NC1=CC=CC(C#N)=C1 UXCYPHCFQAFVFH-UHFFFAOYSA-N 0.000 description 1
125000000972 4,5-dimethylthiazol-2-yl group Chemical group [H]C([H])([H])C1=C(N=C(*)S1)C([H])([H])[H] 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
BJSOSHBGDPCFLO-UHFFFAOYSA-N 4-(4-isocyanatophenyl)morpholine Chemical compound C1=CC(N=C=O)=CC=C1N1CCOCC1 BJSOSHBGDPCFLO-UHFFFAOYSA-N 0.000 description 1
ZOJLVOYGWORFEK-UHFFFAOYSA-N 4-(4-isothiocyanatophenyl)piperazine-1-carboxamide Chemical compound C1CN(C(=O)N)CCN1C1=CC=C(N=C=S)C=C1 ZOJLVOYGWORFEK-UHFFFAOYSA-N 0.000 description 1
QTYRAOOHLZVFGP-UHFFFAOYSA-N 4-(4-nitrophenyl)piperazine-1-carboxamide Chemical compound C1CN(C(=O)N)CCN1C1=CC=C([N+]([O-])=O)C=C1 QTYRAOOHLZVFGP-UHFFFAOYSA-N 0.000 description 1
XBXSGMVYJPSYLI-UHFFFAOYSA-N 4-(4-nitrophenyl)pyridine Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=CC=NC=C1 XBXSGMVYJPSYLI-UHFFFAOYSA-N 0.000 description 1
IRHIMRCEUXJBGP-UHFFFAOYSA-N 4-(4-nitrophenyl)thiomorpholine Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CCSCC1 IRHIMRCEUXJBGP-UHFFFAOYSA-N 0.000 description 1
QIKYZXDTTPVVAC-UHFFFAOYSA-N 4-Aminobenzamide Chemical compound NC(=O)C1=CC=C(N)C=C1 QIKYZXDTTPVVAC-UHFFFAOYSA-N 0.000 description 1
CZGCEKJOLUNIFY-UHFFFAOYSA-N 4-Chloronitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1 CZGCEKJOLUNIFY-UHFFFAOYSA-N 0.000 description 1
ZZLCFHIKESPLTH-UHFFFAOYSA-N 4-Methylbiphenyl Chemical compound C1=CC(C)=CC=C1C1=CC=CC=C1 ZZLCFHIKESPLTH-UHFFFAOYSA-N 0.000 description 1
BOPQOIIMALIAPK-UHFFFAOYSA-N 4-[4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]-1-methylpiperazin-2-one Chemical compound C1C(=O)N(C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 BOPQOIIMALIAPK-UHFFFAOYSA-N 0.000 description 1
FWVIJEGCOSNGIO-UHFFFAOYSA-N 4-[4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]piperazin-2-one Chemical compound S1C(C(=O)C=2C(=CC=CC=2F)F)=C(N)N=C1NC(C=C1)=CC=C1N1CCNC(=O)C1 FWVIJEGCOSNGIO-UHFFFAOYSA-N 0.000 description 1
RVANXWKYZJELFC-UHFFFAOYSA-N 4-[4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]piperazine-1-carboxamide Chemical compound C1CN(C(=O)N)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 RVANXWKYZJELFC-UHFFFAOYSA-N 0.000 description 1
WYFOHGINPKVTRJ-UHFFFAOYSA-N 4-[4-amino-2-(4-sulfamoylanilino)-1,3-thiazole-5-carbonyl]benzoic acid Chemical compound S1C(C(=O)C=2C=CC(=CC=2)C(O)=O)=C(N)N=C1NC1=CC=C(S(N)(=O)=O)C=C1 WYFOHGINPKVTRJ-UHFFFAOYSA-N 0.000 description 1
SBZJLJGNBZHGIU-UHFFFAOYSA-N 4-[[4-amino-5-(1,5-dimethylimidazole-4-carbonyl)-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound N1=CN(C)C(C)=C1C(=O)C1=C(N)N=C(NC=2C=CC(=CC=2)S(N)(=O)=O)S1 SBZJLJGNBZHGIU-UHFFFAOYSA-N 0.000 description 1
BCGFPRUHQNWFMI-UHFFFAOYSA-N 4-[[4-amino-5-(2,5-dimethylthiophene-3-carbonyl)-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound S1C(C)=CC(C(=O)C2=C(N=C(NC=3C=CC(=CC=3)S(N)(=O)=O)S2)N)=C1C BCGFPRUHQNWFMI-UHFFFAOYSA-N 0.000 description 1
AGRFGQCPWLFPIE-UHFFFAOYSA-N 4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]-n,n-dimethylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 AGRFGQCPWLFPIE-UHFFFAOYSA-N 0.000 description 1
FVYBUGFLEXZTAH-UHFFFAOYSA-N 4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]-n-methylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)NC)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 FVYBUGFLEXZTAH-UHFFFAOYSA-N 0.000 description 1
BWWQFAUYHCRZKB-UHFFFAOYSA-N 4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound S1C(C(=O)C=2C(=CC=CC=2F)F)=C(N)N=C1NC1=CC=C(S(N)(=O)=O)C=C1 BWWQFAUYHCRZKB-UHFFFAOYSA-N 0.000 description 1
QLRVHAYRHSFQML-UHFFFAOYSA-N 4-[[4-amino-5-(2-nitrobenzoyl)-1,3-thiazol-2-yl]amino]benzoic acid Chemical compound S1C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)=C(N)N=C1NC1=CC=C(C(O)=O)C=C1 QLRVHAYRHSFQML-UHFFFAOYSA-N 0.000 description 1
VPEHKELGPQENPO-UHFFFAOYSA-N 4-[[4-amino-5-(2-oxo-3,4-dihydro-1h-quinoline-6-carbonyl)-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound S1C(C(=O)C=2C=C3CCC(=O)NC3=CC=2)=C(N)N=C1NC1=CC=C(S(N)(=O)=O)C=C1 VPEHKELGPQENPO-UHFFFAOYSA-N 0.000 description 1
VVMBWKLPWTXGID-UHFFFAOYSA-N 4-[[4-amino-5-(3,5-dibromothiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound S1C(C(=O)C2=C(C=C(Br)S2)Br)=C(N)N=C1NC1=CC=C(S(N)(=O)=O)C=C1 VVMBWKLPWTXGID-UHFFFAOYSA-N 0.000 description 1
NUUIOYQYDAVYTD-UHFFFAOYSA-N 4-[[4-amino-5-(3,5-dimethylpyridine-4-carbonyl)-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound CC1=CN=CC(C)=C1C(=O)C1=C(N)N=C(NC=2C=CC(=CC=2)S(N)(=O)=O)S1 NUUIOYQYDAVYTD-UHFFFAOYSA-N 0.000 description 1
OYPPOFHRJVONRN-UHFFFAOYSA-N 4-[[4-amino-5-(3-methyl-1-benzothiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound S1C2=CC=CC=C2C(C)=C1C(=O)C(=C(N=1)N)SC=1NC1=CC=C(S(N)(=O)=O)C=C1 OYPPOFHRJVONRN-UHFFFAOYSA-N 0.000 description 1
VJDQOVBBWJZBQI-UHFFFAOYSA-N 4-[[4-amino-5-(3-methylthiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]-n-methylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)NC)=CC=C1NC1=NC(N)=C(C(=O)C2=C(C=CS2)C)S1 VJDQOVBBWJZBQI-UHFFFAOYSA-N 0.000 description 1
PXACTUVBBMDKRW-UHFFFAOYSA-N 4-bromobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Br)C=C1 PXACTUVBBMDKRW-UHFFFAOYSA-N 0.000 description 1
LVOASPZGXNAHJI-UHFFFAOYSA-N 4-imidazol-1-ylaniline Chemical compound C1=CC(N)=CC=C1N1C=NC=C1 LVOASPZGXNAHJI-UHFFFAOYSA-N 0.000 description 1
IYSAYSBNKDUNKZ-UHFFFAOYSA-N 4-isocyanatobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(N=C=O)C=C1 IYSAYSBNKDUNKZ-UHFFFAOYSA-N 0.000 description 1
ZAIFZABYMYTEAX-UHFFFAOYSA-N 4-isothiocyanato-n,n-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(N=C=S)C=C1 ZAIFZABYMYTEAX-UHFFFAOYSA-N 0.000 description 1
PHNDZBFLOPIMSM-UHFFFAOYSA-N 4-morpholin-4-ylaniline Chemical compound C1=CC(N)=CC=C1N1CCOCC1 PHNDZBFLOPIMSM-UHFFFAOYSA-N 0.000 description 1
MGYGFNQQGAQEON-UHFFFAOYSA-N 4-tolyl isocyanate Chemical compound CC1=CC=C(N=C=O)C=C1 MGYGFNQQGAQEON-UHFFFAOYSA-N 0.000 description 1
MBLHLRLBSIWLMG-UHFFFAOYSA-N 5-Acetyl-4-methylthiazole Chemical compound CC(=O)C=1SC=NC=1C MBLHLRLBSIWLMG-UHFFFAOYSA-N 0.000 description 1
UVVSPZKAEJHDCY-UHFFFAOYSA-N 5-isothiocyanato-1,3-benzodioxole Chemical compound S=C=NC1=CC=C2OCOC2=C1 UVVSPZKAEJHDCY-UHFFFAOYSA-N 0.000 description 1
CCMOBQFBGOEGEN-UHFFFAOYSA-N 6-(2-bromoacetyl)-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=CC(C(=O)CBr)=CC=C21 CCMOBQFBGOEGEN-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical class N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
229910014265 BrCl Inorganic materials 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
YOOPVIUMRHGFTB-UHFFFAOYSA-O CC(C)(C)OC(N(CC1)CCN1C1=NC(N)=C(C(C(C(Cl)=CC=C2NC(C)=O)=C2Cl)=O)[S+]1N)=O Chemical compound CC(C)(C)OC(N(CC1)CCN1C1=NC(N)=C(C(C(C(Cl)=CC=C2NC(C)=O)=C2Cl)=O)[S+]1N)=O YOOPVIUMRHGFTB-UHFFFAOYSA-O 0.000 description 1
102100027207 CD27 antigen Human genes 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
208000017897 Carcinoma of esophagus Diseases 0.000 description 1
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
241001480079 Corymbia calophylla Species 0.000 description 1
108010060385 Cyclin B1 Proteins 0.000 description 1
229940122541 Cyclin E inhibitor Drugs 0.000 description 1
108010025454 Cyclin-Dependent Kinase 5 Proteins 0.000 description 1
108010016777 Cyclin-Dependent Kinase Inhibitor p27 Proteins 0.000 description 1
102100026805 Cyclin-dependent-like kinase 5 Human genes 0.000 description 1
230000004543 DNA replication Effects 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
244000166102 Eucalyptus leucoxylon Species 0.000 description 1
235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
206010018338 Glioma Diseases 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
239000007821 HATU Substances 0.000 description 1
102000006947 Histones Human genes 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 1
101000868333 Homo sapiens Cyclin-dependent kinase 1 Proteins 0.000 description 1
101000715854 Homo sapiens Cyclin-dependent kinase 2 Proteins 0.000 description 1
101000944380 Homo sapiens Cyclin-dependent kinase inhibitor 1 Proteins 0.000 description 1
101000944361 Homo sapiens Cyclin-dependent kinase inhibitor 1B Proteins 0.000 description 1
101000980932 Homo sapiens Cyclin-dependent kinase inhibitor 2A Proteins 0.000 description 1
101000738559 Homo sapiens G1/S-specific cyclin-D3 Proteins 0.000 description 1
101000733249 Homo sapiens Tumor suppressor ARF Proteins 0.000 description 1
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
240000007472 Leucaena leucocephala Species 0.000 description 1
235000010643 Leucaena leucocephala Nutrition 0.000 description 1
229910010082 LiAlH Inorganic materials 0.000 description 1
235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
208000029578 Muscle disease Diseases 0.000 description 1
208000021642 Muscular disease Diseases 0.000 description 1
PKFSRGHCQXWWPG-UHFFFAOYSA-N NC=1N=C(SC=1C(C1=C(C=CC=C1F)F)=O)NC1=CC=C(C=C1)CNCCC#N Chemical compound NC=1N=C(SC=1C(C1=C(C=CC=C1F)F)=O)NC1=CC=C(C=C1)CNCCC#N PKFSRGHCQXWWPG-UHFFFAOYSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
ISTBRHIZZJIVNT-FBMGVBCBSA-N OC1=CC=CC=C1C1=CS\C(=N\C#N)N1C1=CC=C([N+]([O-])=O)C=C1 Chemical compound OC1=CC=CC=C1C1=CS\C(=N\C#N)N1C1=CC=C([N+]([O-])=O)C=C1 ISTBRHIZZJIVNT-FBMGVBCBSA-N 0.000 description 1
206010030155 Oesophageal carcinoma Diseases 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
229920001214 Polysorbate 60 Polymers 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
102000001253 Protein Kinase Human genes 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
108091006627 SLC12A9 Proteins 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
239000004280 Sodium formate Substances 0.000 description 1
HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
230000006052 T cell proliferation Effects 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 1
CRBJHHDSZBSVFB-UHFFFAOYSA-N [2-(2-bromoacetyl)phenyl] benzoate Chemical compound BrCC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1 CRBJHHDSZBSVFB-UHFFFAOYSA-N 0.000 description 1
GKPQAXNEUSDRJJ-UHFFFAOYSA-N [4-(2-bromoacetyl)phenyl] benzoate Chemical compound C1=CC(C(=O)CBr)=CC=C1OC(=O)C1=CC=CC=C1 GKPQAXNEUSDRJJ-UHFFFAOYSA-N 0.000 description 1
RTENCMRIXNXTCA-UHFFFAOYSA-N [4-amino-2-(1,3-benzodioxol-5-ylamino)-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound NC=1N=C(NC=2C=C3OCOC3=CC=2)SC=1C(=O)C1=CC=CC=C1[N+]([O-])=O RTENCMRIXNXTCA-UHFFFAOYSA-N 0.000 description 1
MTDGBBAJXPYHDB-UHFFFAOYSA-N [4-amino-2-(2-phenylethylamino)-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)=C(N)N=C1NCCC1=CC=CC=C1 MTDGBBAJXPYHDB-UHFFFAOYSA-N 0.000 description 1
DYPZPQVFSRJRQE-UHFFFAOYSA-N [4-amino-2-(3-methoxypropylamino)-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound S1C(NCCCOC)=NC(N)=C1C(=O)C1=CC=CC=C1[N+]([O-])=O DYPZPQVFSRJRQE-UHFFFAOYSA-N 0.000 description 1
OTMUNGINEKEALP-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(1,5-dimethylimidazol-4-yl)methanone Chemical compound N1=CN(C)C(C)=C1C(=O)C1=C(N)N=C(NC=2C=C3NC=NC3=CC=2)S1 OTMUNGINEKEALP-UHFFFAOYSA-N 0.000 description 1
BIVRCRRDUDDZGW-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(1-methylpyrrol-2-yl)methanone Chemical compound CN1C=CC=C1C(=O)C1=C(N)N=C(NC=2C=C3N=CNC3=CC=2)S1 BIVRCRRDUDDZGW-UHFFFAOYSA-N 0.000 description 1
OBRDOSLEKOYSML-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(2,3,6-trimethylphenyl)methanone Chemical compound CC1=CC=C(C)C(C(=O)C2=C(N=C(NC=3C=C4NC=NC4=CC=3)S2)N)=C1C OBRDOSLEKOYSML-UHFFFAOYSA-N 0.000 description 1
WAAYVEJBXFQXKE-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)C1=C(N)N=C(NC=2C=C3NC=NC3=CC=2)S1 WAAYVEJBXFQXKE-UHFFFAOYSA-N 0.000 description 1
OZAGOWUOWSCJSF-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(2,4-dimethylphenyl)methanone Chemical compound CC1=CC(C)=CC=C1C(=O)C1=C(N)N=C(NC=2C=C3NC=NC3=CC=2)S1 OZAGOWUOWSCJSF-UHFFFAOYSA-N 0.000 description 1
CWDLOCNNWJHLIJ-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(2,5-dichlorothiophen-3-yl)methanone Chemical compound NC=1N=C(NC=2C=C3NC=NC3=CC=2)SC=1C(=O)C=1C=C(Cl)SC=1Cl CWDLOCNNWJHLIJ-UHFFFAOYSA-N 0.000 description 1
KLHVZCXPYUCELW-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(2,6-dichloro-3-nitrophenyl)methanone Chemical compound NC=1N=C(NC=2C=C3NC=NC3=CC=2)SC=1C(=O)C1=C(Cl)C=CC([N+]([O-])=O)=C1Cl KLHVZCXPYUCELW-UHFFFAOYSA-N 0.000 description 1
SMSWFIOVSIEMHX-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(2,6-dimethylphenyl)methanone Chemical compound CC1=CC=CC(C)=C1C(=O)C1=C(N)N=C(NC=2C=C3NC=NC3=CC=2)S1 SMSWFIOVSIEMHX-UHFFFAOYSA-N 0.000 description 1
GQDSSLIRAGPQHZ-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(2-bromo-6-methylphenyl)methanone Chemical compound CC1=CC=CC(Br)=C1C(=O)C1=C(N)N=C(NC=2C=C3NC=NC3=CC=2)S1 GQDSSLIRAGPQHZ-UHFFFAOYSA-N 0.000 description 1
OWPHBSYXWMPNFA-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(2-methoxyphenyl)methanone Chemical compound COC1=CC=CC=C1C(=O)C1=C(N)N=C(NC=2C=C3NC=NC3=CC=2)S1 OWPHBSYXWMPNFA-UHFFFAOYSA-N 0.000 description 1
GCVUTWCYUBNCJF-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(2-methyl-6-phenylphenyl)methanone Chemical compound S1C(NC=2C=C3NC=NC3=CC=2)=NC(N)=C1C(=O)C=1C(C)=CC=CC=1C1=CC=CC=C1 GCVUTWCYUBNCJF-UHFFFAOYSA-N 0.000 description 1
IZXFXUGHZKGBDM-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound NC=1N=C(NC=2C=C3NC=NC3=CC=2)SC=1C(=O)C1=CC=CC=C1[N+]([O-])=O IZXFXUGHZKGBDM-UHFFFAOYSA-N 0.000 description 1
AWIIRUDSAHCGLG-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(3,5-dibromothiophen-2-yl)methanone Chemical compound NC=1N=C(NC=2C=C3NC=NC3=CC=2)SC=1C(=O)C=1SC(Br)=CC=1Br AWIIRUDSAHCGLG-UHFFFAOYSA-N 0.000 description 1
YDWHWUFVIPACNN-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(3,5-dichloropyridin-4-yl)methanone Chemical compound NC=1N=C(NC=2C=C3N=CNC3=CC=2)SC=1C(=O)C1=C(Cl)C=NC=C1Cl YDWHWUFVIPACNN-UHFFFAOYSA-N 0.000 description 1
JQXMPNSGOQOWQR-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(3-amino-2,6-dichlorophenyl)methanone Chemical compound NC=1N=C(NC=2C=C3NC=NC3=CC=2)SC=1C(=O)C1=C(Cl)C=CC(N)=C1Cl JQXMPNSGOQOWQR-UHFFFAOYSA-N 0.000 description 1
IHQSJJTZGRLKGV-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(3-amino-4-bromo-2,6-dichlorophenyl)methanone Chemical compound NC=1N=C(NC=2C=C3NC=NC3=CC=2)SC=1C(=O)C1=C(Cl)C=C(Br)C(N)=C1Cl IHQSJJTZGRLKGV-UHFFFAOYSA-N 0.000 description 1
ZUWXRRLZGGXPFU-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(3-methyl-1-benzothiophen-2-yl)methanone Chemical compound C1=C2N=CNC2=CC(NC=2SC(=C(N=2)N)C(=O)C2=C(C3=CC=CC=C3S2)C)=C1 ZUWXRRLZGGXPFU-UHFFFAOYSA-N 0.000 description 1
VCYWUFOQWBGVJV-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(3-methyl-5-nitrothiophen-2-yl)methanone Chemical compound C1=C([N+]([O-])=O)SC(C(=O)C2=C(N=C(NC=3C=C4NC=NC4=CC=3)S2)N)=C1C VCYWUFOQWBGVJV-UHFFFAOYSA-N 0.000 description 1
ZKILFAZIPUPLRH-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-(3-methylthiophen-2-yl)methanone Chemical compound C1=CSC(C(=O)C2=C(N=C(NC=3C=C4NC=NC4=CC=3)S2)N)=C1C ZKILFAZIPUPLRH-UHFFFAOYSA-N 0.000 description 1
RZYBHVJBCQROMJ-UHFFFAOYSA-N [4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazol-5-yl]-[2,6-dichloro-4-(trifluoromethyl)phenyl]methanone Chemical compound NC=1N=C(NC=2C=C3NC=NC3=CC=2)SC=1C(=O)C1=C(Cl)C=C(C(F)(F)F)C=C1Cl RZYBHVJBCQROMJ-UHFFFAOYSA-N 0.000 description 1
HEONGLFXKHMONY-UHFFFAOYSA-N [4-amino-2-(4-aminoanilino)-1,3-thiazol-5-yl]-phenylmethanone Chemical compound S1C(C(=O)C=2C=CC=CC=2)=C(N)N=C1NC1=CC=C(N)C=C1 HEONGLFXKHMONY-UHFFFAOYSA-N 0.000 description 1
VLDGWGSSNXDIIW-UHFFFAOYSA-N [4-amino-2-(4-imidazol-1-ylanilino)-1,3-thiazol-5-yl]-(2,4-dimethylphenyl)methanone Chemical compound CC1=CC(C)=CC=C1C(=O)C1=C(N)N=C(NC=2C=CC(=CC=2)N2C=NC=C2)S1 VLDGWGSSNXDIIW-UHFFFAOYSA-N 0.000 description 1
CVNYTVOMVCLGQX-UHFFFAOYSA-N [4-amino-2-(4-imidazol-1-ylanilino)-1,3-thiazol-5-yl]-(3-methylthiophen-2-yl)methanone Chemical compound C1=CSC(C(=O)C2=C(N=C(NC=3C=CC(=CC=3)N3C=NC=C3)S2)N)=C1C CVNYTVOMVCLGQX-UHFFFAOYSA-N 0.000 description 1
PHNXVIUIVADYJH-UHFFFAOYSA-N [4-amino-2-(4-iodoanilino)-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)=C(N)N=C1NC1=CC=C(I)C=C1 PHNXVIUIVADYJH-UHFFFAOYSA-N 0.000 description 1
CDDOYUUZLXWROW-UHFFFAOYSA-N [4-amino-2-(4-methoxyanilino)-1,3-thiazol-5-yl]-(2-iodophenyl)methanone Chemical compound C1=CC(OC)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2)I)S1 CDDOYUUZLXWROW-UHFFFAOYSA-N 0.000 description 1
QXFUTDQPZSSOKU-UHFFFAOYSA-N [4-amino-2-(4-methoxyanilino)-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound C1=CC(OC)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)S1 QXFUTDQPZSSOKU-UHFFFAOYSA-N 0.000 description 1
FHICZMOCSXZQIE-UHFFFAOYSA-N [4-amino-2-(4-morpholin-4-ylanilino)-1,3-thiazol-5-yl]-(1,5-dimethylimidazol-4-yl)methanone Chemical compound N1=CN(C)C(C)=C1C(=O)C1=C(N)N=C(NC=2C=CC(=CC=2)N2CCOCC2)S1 FHICZMOCSXZQIE-UHFFFAOYSA-N 0.000 description 1
NLSMXXXHJAHPDZ-UHFFFAOYSA-N [4-amino-2-(4-morpholin-4-ylanilino)-1,3-thiazol-5-yl]-(2,4-dimethylphenyl)methanone Chemical compound CC1=CC(C)=CC=C1C(=O)C1=C(N)N=C(NC=2C=CC(=CC=2)N2CCOCC2)S1 NLSMXXXHJAHPDZ-UHFFFAOYSA-N 0.000 description 1
WJSXLQPFTXUINB-UHFFFAOYSA-N [4-amino-2-(4-morpholin-4-ylanilino)-1,3-thiazol-5-yl]-(2,6-dichloro-3-nitrophenyl)methanone Chemical compound S1C(C(=O)C=2C(=C(C=CC=2Cl)[N+]([O-])=O)Cl)=C(N)N=C1NC(C=C1)=CC=C1N1CCOCC1 WJSXLQPFTXUINB-UHFFFAOYSA-N 0.000 description 1
VCCDQXIHAYXVAR-UHFFFAOYSA-N [4-amino-2-(4-morpholin-4-ylanilino)-1,3-thiazol-5-yl]-(2,6-dichlorophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2Cl)Cl)=C(N)N=C1NC(C=C1)=CC=C1N1CCOCC1 VCCDQXIHAYXVAR-UHFFFAOYSA-N 0.000 description 1
SLGTYODEFAIRMF-UHFFFAOYSA-N [4-amino-2-(4-morpholin-4-ylanilino)-1,3-thiazol-5-yl]-(2,6-dimethylphenyl)methanone Chemical compound CC1=CC=CC(C)=C1C(=O)C1=C(N)N=C(NC=2C=CC(=CC=2)N2CCOCC2)S1 SLGTYODEFAIRMF-UHFFFAOYSA-N 0.000 description 1
YCSKWRZRSQMKPN-UHFFFAOYSA-N [4-amino-2-(4-morpholin-4-ylanilino)-1,3-thiazol-5-yl]-(2-bromo-6-methylphenyl)methanone Chemical compound CC1=CC=CC(Br)=C1C(=O)C1=C(N)N=C(NC=2C=CC(=CC=2)N2CCOCC2)S1 YCSKWRZRSQMKPN-UHFFFAOYSA-N 0.000 description 1
COUOAMUMEAUVIF-UHFFFAOYSA-N [4-amino-2-(4-morpholin-4-ylanilino)-1,3-thiazol-5-yl]-(2-methyl-6-phenylphenyl)methanone Chemical compound S1C(NC=2C=CC(=CC=2)N2CCOCC2)=NC(N)=C1C(=O)C=1C(C)=CC=CC=1C1=CC=CC=C1 COUOAMUMEAUVIF-UHFFFAOYSA-N 0.000 description 1
JRCIYQJGJLDCQT-UHFFFAOYSA-N [4-amino-2-(4-morpholin-4-ylanilino)-1,3-thiazol-5-yl]-(3,5-dichloropyridin-4-yl)methanone Chemical compound S1C(C(=O)C=2C(=CN=CC=2Cl)Cl)=C(N)N=C1NC(C=C1)=CC=C1N1CCOCC1 JRCIYQJGJLDCQT-UHFFFAOYSA-N 0.000 description 1
MBCFGUNBCHGLLX-UHFFFAOYSA-N [4-amino-2-(4-nitroanilino)-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)=C(N)N=C1NC1=CC=C([N+]([O-])=O)C=C1 MBCFGUNBCHGLLX-UHFFFAOYSA-N 0.000 description 1
ZRGSUVYQUQZOJB-UHFFFAOYSA-N [4-amino-2-(4-nitroanilino)-1,3-thiazol-5-yl]-phenylmethanone Chemical compound S1C(C(=O)C=2C=CC=CC=2)=C(N)N=C1NC1=CC=C([N+]([O-])=O)C=C1 ZRGSUVYQUQZOJB-UHFFFAOYSA-N 0.000 description 1
HTSNDMGNKFCUEF-UHFFFAOYSA-N [4-amino-2-(4-phenylmethoxyanilino)-1,3-thiazol-5-yl]-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=C(N)N=C(NC=2C=CC(OCC=3C=CC=CC=3)=CC=2)S1 HTSNDMGNKFCUEF-UHFFFAOYSA-N 0.000 description 1
JZBMSNKGVOCEDO-UHFFFAOYSA-N [4-amino-2-(4-piperazin-1-ylanilino)-1,3-thiazol-5-yl]-(2,4,6-trifluorophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC(F)=CC=2F)F)=C(N)N=C1NC(C=C1)=CC=C1N1CCNCC1 JZBMSNKGVOCEDO-UHFFFAOYSA-N 0.000 description 1
DAZZNWGXOBUZHY-UHFFFAOYSA-N [4-amino-2-(4-piperazin-1-ylanilino)-1,3-thiazol-5-yl]-(3-methylthiophen-2-yl)methanone trihydrochloride Chemical compound Cl.Cl.Cl.C1=CSC(C(=O)C2=C(N=C(NC=3C=CC(=CC=3)N3CCNCC3)S2)N)=C1C DAZZNWGXOBUZHY-UHFFFAOYSA-N 0.000 description 1
NIWXNZYXAARDDR-UHFFFAOYSA-N [4-amino-2-(4-propan-2-ylanilino)-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound C1=CC(C(C)C)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)S1 NIWXNZYXAARDDR-UHFFFAOYSA-N 0.000 description 1
UFKXZIQNNRRTSR-UHFFFAOYSA-N [4-amino-2-(4-thiomorpholin-4-ylanilino)-1,3-thiazol-5-yl]-(2,6-difluorophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2F)F)=C(N)N=C1NC(C=C1)=CC=C1N1CCSCC1 UFKXZIQNNRRTSR-UHFFFAOYSA-N 0.000 description 1
IODLQGYKFYOLIA-UHFFFAOYSA-N [4-amino-2-(pyridin-3-ylamino)-1,3-thiazol-5-yl]-(2,4-dichlorophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC(Cl)=CC=2)Cl)=C(N)N=C1NC1=CC=CN=C1 IODLQGYKFYOLIA-UHFFFAOYSA-N 0.000 description 1
GRHHAEHAIMAGEC-UHFFFAOYSA-N [4-amino-2-(pyridin-3-ylamino)-1,3-thiazol-5-yl]-(2,4-dimethylphenyl)methanone Chemical compound CC1=CC(C)=CC=C1C(=O)C1=C(N)N=C(NC=2C=NC=CC=2)S1 GRHHAEHAIMAGEC-UHFFFAOYSA-N 0.000 description 1
XSEPRLAMFBFHKQ-UHFFFAOYSA-N [4-amino-2-(pyridin-3-ylamino)-1,3-thiazol-5-yl]-(2-methoxyphenyl)methanone Chemical compound COC1=CC=CC=C1C(=O)C1=C(N)N=C(NC=2C=NC=CC=2)S1 XSEPRLAMFBFHKQ-UHFFFAOYSA-N 0.000 description 1
VTYCOYWTVCNMQE-UHFFFAOYSA-N [4-amino-2-(pyridin-3-ylamino)-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)=C(N)N=C1NC1=CC=CN=C1 VTYCOYWTVCNMQE-UHFFFAOYSA-N 0.000 description 1
UTSRCVIJWXRHJQ-UHFFFAOYSA-N [4-amino-2-(pyridin-3-ylamino)-1,3-thiazol-5-yl]-naphthalen-2-ylmethanone Chemical compound S1C(C(=O)C=2C=C3C=CC=CC3=CC=2)=C(N)N=C1NC1=CC=CN=C1 UTSRCVIJWXRHJQ-UHFFFAOYSA-N 0.000 description 1
BAJHHYVAGLHVDY-UHFFFAOYSA-N [4-amino-2-[(2-methoxyphenyl)methylamino]-1,3-thiazol-5-yl]-(5-chloro-1-benzofuran-2-yl)methanone Chemical compound COC1=CC=CC=C1CNC1=NC(N)=C(C(=O)C=2OC3=CC=C(Cl)C=C3C=2)S1 BAJHHYVAGLHVDY-UHFFFAOYSA-N 0.000 description 1
LJFPCKILYHFOJS-UHFFFAOYSA-N [4-amino-2-[(2-methyl-3h-benzimidazol-5-yl)amino]-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound C1=C2NC(C)=NC2=CC=C1NC(S1)=NC(N)=C1C(=O)C1=CC=CC=C1[N+]([O-])=O LJFPCKILYHFOJS-UHFFFAOYSA-N 0.000 description 1
LYXSCUOTHOGIHC-UHFFFAOYSA-N [4-amino-2-[(5-chloro-3-methyl-1-benzothiophen-2-yl)amino]-1,3-thiazol-5-yl]-[4-(dimethylamino)phenyl]methanone Chemical compound C1=CC(N(C)C)=CC=C1C(=O)C1=C(N)N=C(NC2=C(C3=CC(Cl)=CC=C3S2)C)S1 LYXSCUOTHOGIHC-UHFFFAOYSA-N 0.000 description 1
IGVKOOUZRCUQRK-UHFFFAOYSA-N [4-amino-2-[2-(4-chlorophenyl)ethylamino]-1,3-thiazol-5-yl]-(2-methoxyphenyl)methanone Chemical compound COC1=CC=CC=C1C(=O)C1=C(N)N=C(NCCC=2C=CC(Cl)=CC=2)S1 IGVKOOUZRCUQRK-UHFFFAOYSA-N 0.000 description 1
WMZIPVRGTLSKGF-UHFFFAOYSA-N [4-amino-2-[2-(4-chlorophenyl)ethylamino]-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)=C(N)N=C1NCCC1=CC=C(Cl)C=C1 WMZIPVRGTLSKGF-UHFFFAOYSA-N 0.000 description 1
YXJCSTWXBUUQHH-UHFFFAOYSA-N [4-amino-2-[4-(1h-imidazol-2-yl)anilino]-1,3-thiazol-5-yl]-[2,6-dichloro-4-(trifluoromethyl)phenyl]methanone Chemical compound S1C(C(=O)C=2C(=CC(=CC=2Cl)C(F)(F)F)Cl)=C(N)N=C1NC(C=C1)=CC=C1C1=NC=CN1 YXJCSTWXBUUQHH-UHFFFAOYSA-N 0.000 description 1
REGZXZOFZXEOIJ-UHFFFAOYSA-N [4-amino-2-[4-(3,3-dimethylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]-(2,6-difluorophenyl)methanone Chemical compound C1CNC(C)(C)CN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 REGZXZOFZXEOIJ-UHFFFAOYSA-N 0.000 description 1
CRMFPQBGDUQCPY-UHFFFAOYSA-N [4-amino-2-[4-(4-methyl-1,4-diazepan-1-yl)anilino]-1,3-thiazol-5-yl]-(2,6-difluorophenyl)methanone Chemical compound C1CN(C)CCCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 CRMFPQBGDUQCPY-UHFFFAOYSA-N 0.000 description 1
RSYXUOWWMKJRMD-UHFFFAOYSA-N [4-amino-2-[4-(4-methylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]-(2,5-dimethylthiophen-3-yl)methanone Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C2=C(SC(C)=C2)C)S1 RSYXUOWWMKJRMD-UHFFFAOYSA-N 0.000 description 1
IBMFMQONAHFJRX-UHFFFAOYSA-N [4-amino-2-[4-(4-methylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]-(3,5-dichloropyridin-4-yl)methanone Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CN=CC=2Cl)Cl)S1 IBMFMQONAHFJRX-UHFFFAOYSA-N 0.000 description 1
SIHVMELJCFQEAE-UHFFFAOYSA-N [4-amino-2-[4-(4-methylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]-(3-methyl-5-nitrothiophen-2-yl)methanone Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C2=C(C=C(S2)[N+]([O-])=O)C)S1 SIHVMELJCFQEAE-UHFFFAOYSA-N 0.000 description 1
PYMAKRHCOOAROE-UHFFFAOYSA-N [4-amino-2-[4-(4-methylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]-(3-methylthiophen-2-yl)methanone Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C2=C(C=CS2)C)S1 PYMAKRHCOOAROE-UHFFFAOYSA-N 0.000 description 1
AEFIQMNOHGKFKD-UHFFFAOYSA-N [4-amino-2-[4-(4-methylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]-[2,6-dichloro-4-(trifluoromethyl)phenyl]methanone Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC(=CC=2Cl)C(F)(F)F)Cl)S1 AEFIQMNOHGKFKD-UHFFFAOYSA-N 0.000 description 1
QVZIQCVGMKXLJK-UHFFFAOYSA-N [4-amino-2-[4-(4-methylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]-[2-fluoro-6-(trifluoromethyl)phenyl]methanone Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)C(F)(F)F)S1 QVZIQCVGMKXLJK-UHFFFAOYSA-N 0.000 description 1
KOXIWRZYPPKPQD-UHFFFAOYSA-N [4-amino-2-[4-(4-methylpiperazin-1-yl)sulfonylanilino]-1,3-thiazol-5-yl]-(2,6-difluorophenyl)methanone Chemical compound C1CN(C)CCN1S(=O)(=O)C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 KOXIWRZYPPKPQD-UHFFFAOYSA-N 0.000 description 1
UJDWUGRNHFVUGI-UHFFFAOYSA-N [4-amino-2-[4-(4-pyridin-2-ylpiperazin-1-yl)anilino]-1,3-thiazol-5-yl]-(2,6-difluorophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2F)F)=C(N)N=C1NC(C=C1)=CC=C1N(CC1)CCN1C1=CC=CC=N1 UJDWUGRNHFVUGI-UHFFFAOYSA-N 0.000 description 1
BTHVGDSEJMYACY-UHFFFAOYSA-N [4-amino-2-[4-(diethylamino)anilino]-1,3-thiazol-5-yl]-(4-nitrophenyl)methanone Chemical compound C1=CC(N(CC)CC)=CC=C1NC1=NC(N)=C(C(=O)C=2C=CC(=CC=2)[N+]([O-])=O)S1 BTHVGDSEJMYACY-UHFFFAOYSA-N 0.000 description 1
LQNQHENNTXNZKG-UHFFFAOYSA-N [4-amino-2-[4-(dimethylamino)anilino]-1,3-thiazol-5-yl]-(2-aminophenyl)methanone Chemical compound C1=CC(N(C)C)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2)N)S1 LQNQHENNTXNZKG-UHFFFAOYSA-N 0.000 description 1
FKXQQTJWLPUFQR-UHFFFAOYSA-N [4-amino-2-[4-(dimethylamino)anilino]-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound C1=CC(N(C)C)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)S1 FKXQQTJWLPUFQR-UHFFFAOYSA-N 0.000 description 1
UZWJDBXVKOXKRK-UHFFFAOYSA-N [4-amino-2-[4-(dimethylamino)anilino]-1,3-thiazol-5-yl]-(3-methyl-1-benzothiophen-2-yl)methanone Chemical compound C1=CC(N(C)C)=CC=C1NC1=NC(N)=C(C(=O)C2=C(C3=CC=CC=C3S2)C)S1 UZWJDBXVKOXKRK-UHFFFAOYSA-N 0.000 description 1
VJGJVLJVZNXVKN-UHFFFAOYSA-N [4-amino-2-[4-(dimethylamino)anilino]-1,3-thiazol-5-yl]-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=C(N)N=C(NC=2C=CC(=CC=2)N(C)C)S1 VJGJVLJVZNXVKN-UHFFFAOYSA-N 0.000 description 1
DBOBGCKGCDMKIM-BETUJISGSA-N [4-amino-2-[4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]anilino]-1,3-thiazol-5-yl]-(2,6-difluorophenyl)methanone Chemical compound C1[C@@H](C)N[C@@H](C)CN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 DBOBGCKGCDMKIM-BETUJISGSA-N 0.000 description 1
MDPRSZJQUYGJIW-UHFFFAOYSA-N [4-amino-2-[4-[2-(dimethylamino)ethyl-methylamino]anilino]-1,3-thiazol-5-yl]-(2,6-difluorophenyl)methanone Chemical compound C1=CC(N(C)CCN(C)C)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 MDPRSZJQUYGJIW-UHFFFAOYSA-N 0.000 description 1
BQKOIZFJEZDBJA-UHFFFAOYSA-N [4-amino-2-[4-[2-(dimethylamino)ethyl-methylamino]anilino]-1,3-thiazol-5-yl]-(3-methylthiophen-2-yl)methanone Chemical compound C1=CC(N(C)CCN(C)C)=CC=C1NC1=NC(N)=C(C(=O)C2=C(C=CS2)C)S1 BQKOIZFJEZDBJA-UHFFFAOYSA-N 0.000 description 1
IFNJTRUECWFSRB-UHFFFAOYSA-N [4-amino-2-[4-[3-(dimethylamino)propyl-methylamino]anilino]-1,3-thiazol-5-yl]-(2,6-difluorophenyl)methanone Chemical compound C1=CC(N(C)CCCN(C)C)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 IFNJTRUECWFSRB-UHFFFAOYSA-N 0.000 description 1
YMYLUDCDPLTKDD-UHFFFAOYSA-N [4-amino-2-[4-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]anilino]-1,3-thiazol-5-yl]-(2,6-difluorophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2F)F)=C(N)N=C1NC(C=C1)=CC=C1N1CCN(CC(F)(F)F)CC1 YMYLUDCDPLTKDD-UHFFFAOYSA-N 0.000 description 1
PZXRFWNZKBANPS-UHFFFAOYSA-N [4-amino-2-[4-[4-(cyclopropylmethyl)piperazin-1-yl]anilino]-1,3-thiazol-5-yl]-(2,6-difluorophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2F)F)=C(N)N=C1NC(C=C1)=CC=C1N(CC1)CCN1CC1CC1 PZXRFWNZKBANPS-UHFFFAOYSA-N 0.000 description 1
QTQLJTICQAXTBW-UHFFFAOYSA-N [4-amino-2-[4-[[2-chloro-5-(trifluoromethyl)-1h-pyridin-2-yl]sulfanyl]anilino]-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone Chemical compound S1C(C(=O)C=2C(=CC=CC=2)[N+]([O-])=O)=C(N)N=C1NC(C=C1)=CC=C1SC1(Cl)NC=C(C(F)(F)F)C=C1 QTQLJTICQAXTBW-UHFFFAOYSA-N 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
230000009471 action Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
239000003513 alkali Substances 0.000 description 1
150000001342 alkaline earth metals Chemical class 0.000 description 1
125000006177 alkyl benzyl group Chemical group 0.000 description 1
125000005157 alkyl carboxy group Chemical group 0.000 description 1
125000005037 alkyl phenyl group Chemical group 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
LGMSNQNWOCSPIK-LWHGMNCYSA-N alvocidib hydrochloride Chemical compound Cl.O[C@@H]1CN(C)CC[C@@H]1C1=C(O)C=C(O)C2=C1OC(C=1C(=CC=CC=1)Cl)=CC2=O LGMSNQNWOCSPIK-LWHGMNCYSA-N 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
230000003321 amplification Effects 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
229910052786 argon Inorganic materials 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
150000003939 benzylamines Chemical class 0.000 description 1
NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
CODNYICXDISAEA-UHFFFAOYSA-N bromine monochloride Chemical compound BrCl CODNYICXDISAEA-UHFFFAOYSA-N 0.000 description 1
AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 description 1
239000000872 buffer Substances 0.000 description 1
235000019437 butane-1,3-diol Nutrition 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
PASHVRUKOFIRIK-UHFFFAOYSA-L calcium sulfate dihydrate Chemical compound O.O.[Ca+2].[O-]S([O-])(=O)=O PASHVRUKOFIRIK-UHFFFAOYSA-L 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000018486 cell cycle phase Effects 0.000 description 1
230000006369 cell cycle progression Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
239000013000 chemical inhibitor Substances 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000002026 chloroform extract Substances 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
230000006957 competitive inhibition Effects 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
235000008504 concentrate Nutrition 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000013256 coordination polymer Substances 0.000 description 1
DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000000875 corresponding effect Effects 0.000 description 1
239000013039 cover film Substances 0.000 description 1
239000002178 crystalline material Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
125000002946 cyanobenzyl group Chemical group 0.000 description 1
239000002875 cyclin dependent kinase inhibitor Substances 0.000 description 1
125000000392 cycloalkenyl group Chemical group 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
230000032459 dedifferentiation Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000030609 dephosphorylation Effects 0.000 description 1
238000006209 dephosphorylation reaction Methods 0.000 description 1
230000003831 deregulation Effects 0.000 description 1
VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 1
238000007865 diluting Methods 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
201000005619 esophageal carcinoma Diseases 0.000 description 1
AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
239000012259 ether extract Substances 0.000 description 1
BJPWLYQGLIRJLZ-UHFFFAOYSA-N ethyl 3-isothiocyanatobutanoate Chemical compound CCOC(=O)CC(C)N=C=S BJPWLYQGLIRJLZ-UHFFFAOYSA-N 0.000 description 1
XMIVTAOFQJBIGO-UHFFFAOYSA-N ethyl 4-(2-bromoacetyl)benzoate Chemical compound CCOC(=O)C1=CC=C(C(=O)CBr)C=C1 XMIVTAOFQJBIGO-UHFFFAOYSA-N 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000004880 explosion Methods 0.000 description 1
229930003944 flavone Natural products 0.000 description 1
150000002212 flavone derivatives Chemical class 0.000 description 1
235000011949 flavones Nutrition 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
230000014509 gene expression Effects 0.000 description 1
230000004077 genetic alteration Effects 0.000 description 1
231100000118 genetic alteration Toxicity 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
229960003180 glutathione Drugs 0.000 description 1
AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical compound OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
229940075507 glyceryl monostearate Drugs 0.000 description 1
229960002449 glycine Drugs 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
201000003911 head and neck carcinoma Diseases 0.000 description 1
125000005842 heteroatom Chemical group 0.000 description 1
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
108010052344 histone H1 kinase Proteins 0.000 description 1
102000056838 human CDK1 Human genes 0.000 description 1
102000054634 human CDK2 Human genes 0.000 description 1
238000005984 hydrogenation reaction Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
230000006951 hyperphosphorylation Effects 0.000 description 1
239000005457 ice water Substances 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
208000026278 immune system disease Diseases 0.000 description 1
238000003119 immunoblot Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
239000011630 iodine Substances 0.000 description 1
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
125000006303 iodophenyl group Chemical group 0.000 description 1
229940045996 isethionic acid Drugs 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
MZSJGCPBOVTKHR-UHFFFAOYSA-N isothiocyanatocyclohexane Chemical compound S=C=NC1CCCCC1 MZSJGCPBOVTKHR-UHFFFAOYSA-N 0.000 description 1
229940043355 kinase inhibitor Drugs 0.000 description 1
TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
239000008101 lactose Substances 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
239000012139 lysis buffer Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
238000005259 measurement Methods 0.000 description 1
JQEICALGZPXFNA-YFKPBYRVSA-N methyl (2s)-2-isothiocyanatobutanoate Chemical compound S=C=N[C@@H](CC)C(=O)OC JQEICALGZPXFNA-YFKPBYRVSA-N 0.000 description 1
YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
NQXFZEJJHPUMMF-UHFFFAOYSA-N methyl 3-isothiocyanatobenzoate Chemical compound COC(=O)C1=CC=CC(N=C=S)=C1 NQXFZEJJHPUMMF-UHFFFAOYSA-N 0.000 description 1
BUZNPMAGIAFLPQ-UHFFFAOYSA-N methyl 4-[[4-amino-5-(4-methoxybenzoyl)-1,3-thiazol-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1NC1=NC(N)=C(C(=O)C=2C=CC(OC)=CC=2)S1 BUZNPMAGIAFLPQ-UHFFFAOYSA-N 0.000 description 1
WIZODHILGBTPPA-UHFFFAOYSA-N methyl 4-isothiocyanatobenzoate Chemical compound COC(=O)C1=CC=C(N=C=S)C=C1 WIZODHILGBTPPA-UHFFFAOYSA-N 0.000 description 1
125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
239000007758 minimum essential medium Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
DSLXKQYKRYUABO-UHFFFAOYSA-N n'-(4-isothiocyanatophenyl)-n,n,n'-trimethylpropane-1,3-diamine Chemical compound CN(C)CCCN(C)C1=CC=C(N=C=S)C=C1 DSLXKQYKRYUABO-UHFFFAOYSA-N 0.000 description 1
VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
PGIMSBPAYDNSHJ-UHFFFAOYSA-N n,n,n'-trimethyl-n'-(4-nitrophenyl)ethane-1,2-diamine Chemical compound CN(C)CCN(C)C1=CC=C([N+]([O-])=O)C=C1 PGIMSBPAYDNSHJ-UHFFFAOYSA-N 0.000 description 1
ZCWXRMBVAKOURU-UHFFFAOYSA-N n,n-dimethyl-4-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1 ZCWXRMBVAKOURU-UHFFFAOYSA-N 0.000 description 1
KRKPYFLIYNGWTE-UHFFFAOYSA-N n,o-dimethylhydroxylamine Chemical compound CNOC KRKPYFLIYNGWTE-UHFFFAOYSA-N 0.000 description 1
OQHWDKZMXIDGBJ-UHFFFAOYSA-N n-[2-(2-bromoacetyl)-3-chlorophenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(Cl)=C1C(=O)CBr OQHWDKZMXIDGBJ-UHFFFAOYSA-N 0.000 description 1
ZQFWCOUBLQISFV-UHFFFAOYSA-N n-[3-[4-amino-2-(3h-benzimidazol-5-ylamino)-1,3-thiazole-5-carbonyl]-2,4-dichlorophenyl]acetamide Chemical compound CC(=O)NC1=CC=C(Cl)C(C(=O)C2=C(N=C(NC=3C=C4NC=NC4=CC=3)S2)N)=C1Cl ZQFWCOUBLQISFV-UHFFFAOYSA-N 0.000 description 1
RUHUXJXLGFKFJW-UHFFFAOYSA-N n-[3-[4-amino-2-[4-(4-methylpiperazin-1-yl)anilino]-1,3-thiazole-5-carbonyl]-2,4-dichlorophenyl]acetamide Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=C(NC(C)=O)C=CC=2Cl)Cl)S1 RUHUXJXLGFKFJW-UHFFFAOYSA-N 0.000 description 1
VMLOCNJYQNBLAW-UHFFFAOYSA-N n-[5-(2-hydroxybenzoyl)-2-(4-nitroanilino)-1,3-thiazol-4-yl]benzamide Chemical compound OC1=CC=CC=C1C(=O)C1=C(NC(=O)C=2C=CC=CC=2)N=C(NC=2C=CC(=CC=2)[N+]([O-])=O)S1 VMLOCNJYQNBLAW-UHFFFAOYSA-N 0.000 description 1
LSJIXYOXWLWCDT-UHFFFAOYSA-N n-methoxy-n,1,5-trimethylimidazole-4-carboxamide Chemical compound CON(C)C(=O)C=1N=CN(C)C=1C LSJIXYOXWLWCDT-UHFFFAOYSA-N 0.000 description 1
XIFJZJPMHNUGRA-UHFFFAOYSA-N n-methyl-4-nitroaniline Chemical compound CNC1=CC=C([N+]([O-])=O)C=C1 XIFJZJPMHNUGRA-UHFFFAOYSA-N 0.000 description 1
VRLPFKWKOHFJAB-UHFFFAOYSA-N n-phenyl-1h-pyrrol-2-amine Chemical compound C=1C=CC=CC=1NC1=CC=CN1 VRLPFKWKOHFJAB-UHFFFAOYSA-N 0.000 description 1
230000017066 negative regulation of growth Effects 0.000 description 1
230000027405 negative regulation of phosphorylation Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
125000004433 nitrogen atom Chemical group N* 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
125000001209 o-nitrophenyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])[N+]([O-])=O 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
230000000771 oncological effect Effects 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
201000002528 pancreatic cancer Diseases 0.000 description 1
210000004923 pancreatic tissue Anatomy 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
238000009521 phase II clinical trial Methods 0.000 description 1
IZJDOKYDEWTZSO-UHFFFAOYSA-N phenethyl isothiocyanate Chemical compound S=C=NCCC1=CC=CC=C1 IZJDOKYDEWTZSO-UHFFFAOYSA-N 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
OLNKRVAPLUJIKO-UHFFFAOYSA-N phenyl 4-[4-amino-2-(4-sulfamoylanilino)-1,3-thiazole-5-carbonyl]benzoate Chemical compound S1C(C(=O)C=2C=CC(=CC=2)C(=O)OC=2C=CC=CC=2)=C(N)N=C1NC1=CC=C(S(N)(=O)=O)C=C1 OLNKRVAPLUJIKO-UHFFFAOYSA-N 0.000 description 1
FCJSHPDYVMKCHI-UHFFFAOYSA-N phenyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OC1=CC=CC=C1 FCJSHPDYVMKCHI-UHFFFAOYSA-N 0.000 description 1
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000003757 phosphotransferase inhibitor Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical compound O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 description 1
150000003053 piperidines Chemical class 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
235000013824 polyphenols Nutrition 0.000 description 1
229940113124 polysorbate 60 Drugs 0.000 description 1
229940068968 polysorbate 80 Drugs 0.000 description 1
238000010837 poor prognosis Methods 0.000 description 1
239000011591 potassium Substances 0.000 description 1
GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 1
239000004302 potassium sorbate Substances 0.000 description 1
235000010241 potassium sorbate Nutrition 0.000 description 1
229940069338 potassium sorbate Drugs 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229960004063 propylene glycol Drugs 0.000 description 1
235000013772 propylene glycol Nutrition 0.000 description 1
229940121649 protein inhibitor Drugs 0.000 description 1
239000012268 protein inhibitor Substances 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
GZRKXKUVVPSREJ-UHFFFAOYSA-N pyridinylpiperazine Chemical compound C1CNCCN1C1=CC=CC=N1 GZRKXKUVVPSREJ-UHFFFAOYSA-N 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
150000003235 pyrrolidines Chemical class 0.000 description 1
125000001453 quaternary ammonium group Chemical group 0.000 description 1
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
230000026267 regulation of growth Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
230000028617 response to DNA damage stimulus Effects 0.000 description 1
208000037803 restenosis Diseases 0.000 description 1
238000012552 review Methods 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
208000000587 small cell lung carcinoma Diseases 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
235000013024 sodium fluoride Nutrition 0.000 description 1
239000011775 sodium fluoride Substances 0.000 description 1
HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
235000019254 sodium formate Nutrition 0.000 description 1
229940048086 sodium pyrophosphate Drugs 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
239000001587 sorbitan monostearate Substances 0.000 description 1
235000011076 sorbitan monostearate Nutrition 0.000 description 1
229940035048 sorbitan monostearate Drugs 0.000 description 1
206010041823 squamous cell carcinoma Diseases 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
239000012058 sterile packaged powder Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
230000008685 targeting Effects 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
MFHZMCHOPGVYFZ-IYBDPMFKSA-N tert-butyl (2r,6s)-4-[4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]-2,6-dimethylpiperazine-1-carboxylate Chemical compound C1[C@@H](C)N(C(=O)OC(C)(C)C)[C@@H](C)CN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 MFHZMCHOPGVYFZ-IYBDPMFKSA-N 0.000 description 1
WERLWDBLJLNYAC-OKILXGFUSA-N tert-butyl (2s,6r)-4-(4-isothiocyanatophenyl)-2,6-dimethylpiperazine-1-carboxylate Chemical compound C1[C@@H](C)N(C(=O)OC(C)(C)C)[C@@H](C)CN1C1=CC=C(N=C=S)C=C1 WERLWDBLJLNYAC-OKILXGFUSA-N 0.000 description 1
RNLQHMIDSCYLAK-UHFFFAOYSA-N tert-butyl 2-(methylamino)acetate;hydron;chloride Chemical compound Cl.CNCC(=O)OC(C)(C)C RNLQHMIDSCYLAK-UHFFFAOYSA-N 0.000 description 1
MHYOKZQFAQMTSH-UHFFFAOYSA-N tert-butyl 4-(4-aminophenyl)-3,5-dimethylpiperazine-1-carboxylate Chemical compound CC1CN(C(=O)OC(C)(C)C)CC(C)N1C1=CC=C(N)C=C1 MHYOKZQFAQMTSH-UHFFFAOYSA-N 0.000 description 1
LORCKFPWKRKGLV-UHFFFAOYSA-N tert-butyl 4-[4-[[4-amino-5-(2,4,6-trifluorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC(F)=CC=2F)F)S1 LORCKFPWKRKGLV-UHFFFAOYSA-N 0.000 description 1
NKURRHIZOJJPSC-UHFFFAOYSA-N tert-butyl 4-[4-[[4-amino-5-(2,6-dichlorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2Cl)Cl)S1 NKURRHIZOJJPSC-UHFFFAOYSA-N 0.000 description 1
MFHZMCHOPGVYFZ-UHFFFAOYSA-N tert-butyl 4-[4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]-2,6-dimethylpiperazine-1-carboxylate Chemical compound C1C(C)N(C(=O)OC(C)(C)C)C(C)CN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 MFHZMCHOPGVYFZ-UHFFFAOYSA-N 0.000 description 1
LSCMLXOVDHNIDO-UHFFFAOYSA-N tert-butyl 4-[4-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C(C=C1)=CC=C1NC1=NC(N)=C(C(=O)C=2C(=CC=CC=2F)F)S1 LSCMLXOVDHNIDO-UHFFFAOYSA-N 0.000 description 1
YWTDFUNSVBPYRK-UHFFFAOYSA-N tert-butyl 4-[4-[[4-amino-5-(3-methylthiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]phenyl]piperazine-1-carboxylate Chemical compound C1=CSC(C(=O)C2=C(N=C(NC=3C=CC(=CC=3)N3CCN(CC3)C(=O)OC(C)(C)C)S2)N)=C1C YWTDFUNSVBPYRK-UHFFFAOYSA-N 0.000 description 1
AKFYUFMDMIBCQW-UHFFFAOYSA-N tert-butyl 4-[[(4-isothiocyanatophenyl)sulfonylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CNS(=O)(=O)C1=CC=C(N=C=S)C=C1 AKFYUFMDMIBCQW-UHFFFAOYSA-N 0.000 description 1
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
108091008023 transcriptional regulators Proteins 0.000 description 1
VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
238000005406 washing Methods 0.000 description 1
238000001262 western blot Methods 0.000 description 1
229910052727 yttrium Inorganic materials 0.000 description 1
229910000166 zirconium phosphate Inorganic materials 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

LT2000033A 1997-10-27 2000-04-14 Pakeisti 4-amino-tiazol-2-il junginiai kaip nuo ciklino priklausomų kinazių inhibitoriai LT4855B (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6363497P	1997-10-27	1997-10-27
US6366697P	1997-10-28	1997-10-28

Publications (2)

Publication Number	Publication Date
LT2000033A LT2000033A (en)	2001-06-25
LT4855B true LT4855B (lt)	2001-11-26

Family

ID=26743609

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LT2000033A LT4855B (lt)	1997-10-27	2000-04-14	Pakeisti 4-amino-tiazol-2-il junginiai kaip nuo ciklino priklausomų kinazių inhibitoriai

Country Status (34)

Country	Link
US (2)	US6569878B1 (id)
EP (1)	EP1056732B1 (id)
JP (1)	JP2004500304A (id)
KR (1)	KR20010082501A (id)
CN (1)	CN1158269C (id)
AP (1)	AP1445A (id)
AT (2)	ATE315553T1 (id)
AU (1)	AU738792B2 (id)
BG (1)	BG64195B1 (id)
BR (1)	BR9815200A (id)
CA (1)	CA2306082A1 (id)
DE (2)	DE69833223T2 (id)
EA (1)	EA003527B1 (id)
EE (1)	EE200000289A (id)
ES (2)	ES2256968T3 (id)
GE (1)	GEP20032896B (id)
HR (1)	HRP20000222A2 (id)
HU (1)	HUP0004512A3 (id)
ID (1)	ID24372A (id)
IL (1)	IL135574A0 (id)
IS (1)	IS5462A (id)
LT (1)	LT4855B (id)
LV (1)	LV12592B (id)
NO (1)	NO20001955L (id)
NZ (1)	NZ503788A (id)
OA (1)	OA11352A (id)
PL (1)	PL342447A1 (id)
RO (1)	RO119463B1 (id)
SI (1)	SI20324A (id)
SK (1)	SK5212000A3 (id)
TR (1)	TR200001081T2 (id)
UA (1)	UA66810C2 (id)
WO (1)	WO1999021845A2 (id)
YU (1)	YU22400A (id)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ503788A (en) *	1997-10-27	2002-11-26	Agouron Pharma	4-aminothiazole derivatives and their use as inhibitors of cyclin-dependent kinases
UA60365C2 (uk)	1998-06-04	2003-10-15	Пфайзер Продактс Інк.	Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
ES2300151T3 (es) *	1998-09-22	2008-06-01	Astellas Pharma Inc.	Derivados de cianofenilo.
US6214852B1 (en)	1998-10-21	2001-04-10	Bristol-Myers Squibb Company	N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
US6414156B2 (en)	1998-10-21	2002-07-02	Bristol-Myers Squibb Company	Process for preparing azacycloalkanoylaminothiazoles
US7125875B2 (en)	1999-04-15	2006-10-24	Bristol-Myers Squibb Company	Cyclic protein tyrosine kinase inhibitors
PL215901B1 (pl) *	1999-04-15	2014-02-28	Bristol Myers Squibb Co	Cykliczny inhibitor bialkowych kinaz tyrozynowych, jego zastosowanie oraz kompozycja farmaceutyczna zawierajaca taki zwiazek
UA71971C2 (en)	1999-06-04	2005-01-17	Agoron Pharmaceuticals Inc	Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
US7141581B2 (en)	1999-07-02	2006-11-28	Agouron Pharmaceuticals, Inc.	Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
TWI262914B (en)	1999-07-02	2006-10-01	Agouron Pharma	Compounds and pharmaceutical compositions for inhibiting protein kinases
PE20010306A1 (es) *	1999-07-02	2001-03-29	Agouron Pharma	Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
US6114365A (en) *	1999-08-12	2000-09-05	Pharmacia & Upjohn S.P.A.	Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
US6515004B1 (en)	1999-12-15	2003-02-04	Bristol-Myers Squibb Company	N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
US6392053B2 (en)	1999-12-15	2002-05-21	Bristol-Myers Squibb Company	Process for preparing arylacetylaminothiazoles
YU54202A (sh)	2000-01-18	2006-01-16	Agouron Pharmaceuticals Inc.	Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
HN2001000008A (es)	2000-01-21	2003-12-11	Inc Agouron Pharmaceuticals	Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
WO2001056567A1 (en) *	2000-02-04	2001-08-09	Novo Nordisk A/S	2,4-diaminothiazole derivatives and their use as glycogen synthase kinase-3 (gsk-3) inhibitors
JP2004501083A (ja)	2000-04-18	2004-01-15	アゴーロン・ファーマシューティカルズ・インコーポレイテッド	プロテインキナーゼを阻害するためのピラゾール
KR100423899B1 (ko)	2000-05-10	2004-03-24	주식회사 엘지생명과학	세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸
EP1307462A2 (en) *	2000-08-09	2003-05-07	Agouron Pharmaceuticals, Inc.	Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
ATE295354T1 (de)	2000-08-18	2005-05-15	Agouron Pharma	Heterozyklische-hydroximino-fluorene und ihre verwendung zur inhibierung von proteinkinasen
EP1712550A3 (en) *	2000-12-22	2009-07-15	Ortho-McNeil Pharmaceutical, Inc.	Substituted triazole diamine derivatives as kinase inhibitors
DE60120494T2 (de) *	2000-12-22	2006-12-21	Ortho-Mcneil Pharmaceutical, Inc.	Substituieten triazoldiamin derivaten und ihre verwendung als kinase inhibitoren
US6756374B2 (en)	2001-01-22	2004-06-29	Hoffmann-La Roche Inc.	Diaminothiazoles having antiproliferative activity
ATE316088T1 (de) *	2001-06-22	2006-02-15	Merck & Co Inc	Tyrosin-kinase inhibitoren
HN2002000156A (es) *	2001-07-06	2003-11-27	Inc Agouron Pharmaceuticals	Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización.
EP1724270A3 (en)	2001-07-19	2007-01-03	Pfizer Italia S.r.l.	Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
MXPA04000906A (es) *	2001-08-03	2004-11-22	Novo Nordisk As	Nuevos derivados de 2,4-diaminotiazol.
ES2251677T3 (es)	2002-01-22	2006-05-01	Warner-Lambert Company Llc	2-(piridin-2-ilamino)-pirido(2,3-d)pirimidin-7-onas.
US6818663B2 (en) *	2002-05-17	2004-11-16	Hoffmann-La Roches	Diaminothiazoles
UA77303C2 (en)	2002-06-14	2006-11-15	Pfizer	Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use
US6872724B2 (en)	2002-07-24	2005-03-29	Merck & Co., Inc.	Polymorphs with tyrosine kinase activity
EP1527071A1 (en)	2002-07-25	2005-05-04	Pfizer Products Inc.	Isothiazole derivatives useful as anticancer agents
CA2493712A1 (en) *	2002-08-07	2004-02-19	F. Hoffmann-La Roche Ag	Aminothiazole derivatives as npy5 receptor inhibitors
US7157455B2 (en)	2003-02-10	2007-01-02	Hoffmann-La Roche Inc.	4-Aminopyrimidine-5-one derivatives
WO2004072070A1 (en) *	2003-02-12	2004-08-26	Pfizer Inc.	Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives
JP2006518368A (ja) *	2003-02-21	2006-08-10	ファイザー・インク	プロテインキナーゼ阻害剤としてのｎ−ヘテロシクリル置換アミノチアゾール誘導体
US7652044B2 (en)	2003-06-03	2010-01-26	Novartis A.G.	P-38 inhibitors
KR101120857B1 (ko)	2003-06-26	2012-04-12	노파르티스 아게	5원의 헤테로사이클-기재 ｐ38 키나제 억제제
TWI372050B (en)	2003-07-03	2012-09-11	Astex Therapeutics Ltd	(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
PL2256106T3 (pl)	2003-07-22	2015-08-31	Astex Therapeutics Ltd	Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
DK1651615T3 (da)	2003-07-29	2010-05-25	High Point Pharmaceuticals Llc	Pyridazinyl-piperaziner og anvendelse deraf som histamin-H3-receptorligander
US20070275918A1 (en) *	2003-11-07	2007-11-29	The Board Of Trustees Of The University Of Illinois	Induction of Cellular Senescence by Cdk4 Disruption for Tumor Suppression and Regression
US20050171182A1 (en) *	2003-12-11	2005-08-04	Roger Briesewitz	Methods and compositions for use in the treatment of mutant receptor tyrosine kinase driven cellular proliferative diseases
EP1550372A1 (en) *	2003-12-24	2005-07-06	Bayer CropScience GmbH	Plant growth regulation
CA2554925A1 (en) *	2004-01-30	2005-08-11	Ab Science	2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
AU2005230846A1 (en) *	2004-03-31	2005-10-20	Lexicon Pharmaceuticals, Inc.	2-aminomethylthiazole-5-carboxamides as protein kinase modulators
US7211576B2 (en) *	2004-04-20	2007-05-01	Hoffmann-La Roche Inc.	Diaminothiazoles
WO2006078287A2 (en)	2004-05-06	2006-07-27	Plexxikon, Inc.	Pde4b inhibitors and uses therefor
US7405220B2 (en)	2004-06-09	2008-07-29	Hoffmann-La Roche Inc.	Pyrazolopyrimidines
US7423053B2 (en)	2004-07-15	2008-09-09	Hoffmann-La Roche Inc.	4-Aminothiazole derivatives
US7423051B2 (en) *	2004-07-15	2008-09-09	Hoffmann-La Roche Inc.	2,6-diaminopyridine derivatives
US7605168B2 (en)	2004-09-03	2009-10-20	Plexxikon, Inc.	PDE4B inhibitors
US7241893B2 (en) *	2004-09-17	2007-07-10	Hoffman-La Roche Inc.	Thiazolinone 2-substituted quinolines
US7253285B2 (en) *	2004-09-17	2007-08-07	Hoffmann-La Roche Inc.	Thiazolinone 4-monosubstituted quinolines
PL1805175T3 (pl)	2004-10-14	2008-08-29	Hoffmann La Roche	Nowe azaindolotiazolinony jako środki przeciwrakowe
WO2006070192A1 (en)	2004-12-30	2006-07-06	Astex Therapeutics Limited	Thiazole and isothiazole derivatives that modulate the acivity of cdk, gsk and aurora kynases
EP1833819A1 (en)	2004-12-30	2007-09-19	Astex Therapeutics Limited	Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
MX2007008781A (es)	2005-01-21	2007-09-11	Astex Therapeutics Ltd	Compuestos farmaceuticos.
JP5475234B2 (ja)	2005-01-21	2014-04-16	アステックス・セラピューティクス・リミテッド	医薬化合物
US7304074B2 (en)	2005-04-05	2007-12-04	Hoffmann-La Roche Inc.	Substituted 1,5-naphthyridine azolinones
RU2499795C2 (ru)	2005-07-04	2013-11-27	Хай Пойнт Фармасьютикалс, ЛЛС	Антагонисты гистаминовых н3-рецепторов
MX2008001428A (es)	2005-07-30	2008-04-04	Astrazeneca Ab	Compuestos de imidazolil-pirimidina para uso en el tratamiento de trastornos proliferativos.
US7705009B2 (en) *	2005-11-22	2010-04-27	Hoffman-La Roche Inc.	4-aminopyrimidine-5-thione derivatives
MX2008011123A (es)	2006-03-28	2008-09-30	High Point Pharmaceuticals Llc	Benzotiazoles que tienen actividad de receptor h3 de histamina.
US8318927B2 (en)	2006-05-23	2012-11-27	High Point Pharmaceuticals, Llc	6-(4-cyclopropylpiperazin-1-yl)-2′-methyl-[3, 4′]-bipyridine and its uses as a medicament
SG163547A1 (en)	2006-05-29	2010-08-30	High Point Pharmaceuticals Llc	3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
NZ578944A (en) *	2007-02-13	2011-03-31	Ab Science	PROCESS FOR THE SYNTHESIS OF 2-AMINOTHIAZOLE COMPOUNDS SUCH AS 4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-phenyl]-benzamide AS KINASE INHIBITORS
EP2155740B1 (en) *	2007-05-11	2011-01-26	F. Hoffmann-La Roche AG	Hetarylanilines as modulators for amyloid beta
EP2014656A3 (en)	2007-06-11	2011-08-24	High Point Pharmaceuticals, LLC	New heteocyclic h3 antagonists
EP3399026B1 (en)	2010-06-14	2024-06-26	The Scripps Research Institute	Reprogramming of cells to a new fate
UA117342C2 (uk) *	2012-02-02	2018-07-25	Сенекс Біотекнолоджи Інк.	Селективні інгібітори cdk8/cdk19 та їх застосування як протиметастатичних та хіміопрофілактичних засобів у способах лікування раку
CN102977049A (zh) *	2012-11-26	2013-03-20	盛世泰科生物医药技术(苏州)有限公司	一种2-氨基-4-环丙基-5-羧酸乙酯噻唑的合成方法
AU2014262764B2 (en)	2013-05-07	2018-11-15	The Regents Of The University Of California	Radiomitigating pharmaceutical formulations
CN104628627A (zh) *	2014-12-23	2015-05-20	安徽德信佳生物医药有限公司	一种1-boc-4-氨基哌啶的合成方法
CN106854200B (zh) *	2015-12-08	2019-05-21	上海复星星泰医药科技有限公司	色瑞替尼及其中间体的制备方法
WO2018089902A1 (en) *	2016-11-13	2018-05-17	Apogee Biotechnology Corporation	Diaminothiazole compounds, compositions and methods of use
WO2018124001A1 (ja)	2016-12-27	2018-07-05	国立研究開発法人理化学研究所	Ｂｍｐシグナル阻害化合物
EP3571196B1 (en) *	2017-01-19	2023-01-04	Temple University Of The Commonwealth System Of Higher Education	Novel bridged bicycloalkyl-substituted aminothizoles and their methods of use
EP3749654B1 (en)	2018-02-06	2025-04-23	The Board of Trustees of the University of Illinois	Substituted benzothiophene analogs as selective estrogen receptor degraders
CN113292537B (zh)	2018-06-15	2024-04-05	汉达癌症医药责任有限公司	激酶抑制剂的盐类及其组合物
CN109897014A (zh) *	2019-04-17	2019-06-18	成都睿智化学研究有限公司	一种1-（取代苯基）-4-甲基哌嗪的工艺制备方法
CN118453591A (zh) *	2020-09-01	2024-08-09	苏州灵希生物科技有限公司	化合物作为cyp2e1抑制剂的应用
CN114805432A (zh) *	2022-03-03	2022-07-29	西北工业大学	新型可光催化剪切的羧酸保护基及其氨基酸衍生物的制备方法
KR102820358B1 (ko) *	2022-08-30	2025-06-12	한국화학연구원	Mkk3 키나아제 억제 화합물을 함유한 천포창 개선 또는 치료용 조성물
WO2025128616A1 (en) *	2023-12-12	2025-06-19	Genesis Therapeutics, Inc.	Compounds for treating cancer
WO2026024674A1 (en)	2024-07-22	2026-01-29	Genesis Therapeutics, Inc.	Methods of treating skp2-associated cancers

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997016447A1 (en)	1995-10-31	1997-05-09	Mitotix, Inc.	Inhibitors of cyclin-dependent kinases
WO1997042949A1 (en)	1996-05-10	1997-11-20	Bristol-Myers Squibb Company	2-thio or 2-oxo flavopiridol analogs
WO1998017662A1 (en)	1996-10-18	1998-04-30	Novartis Ag	Phenyl-substituted bicyclic heterocyclyl derivatives and their use
WO1998033798A2 (en)	1997-02-05	1998-08-06	Warner Lambert Company	Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3530161A (en)	1968-08-19	1970-09-22	Shell Oil Co	Aromatic isothiocyanate production
BE792402A (fr)	1971-12-07	1973-06-07	Ciba Geigy	Composes heterocycliques azotes et medicaments anthelminthiqueset antimicrobiens qui en contiennent
CH593806A5 (id)	1974-11-14	1977-12-15	Ciba Geigy Ag
US4086239A (en)	1977-07-01	1978-04-25	Stauffer Chemical Company	Thiazole bis-phosphates and phosphonates, intermediates, and insecticidal compositions and methods
US4649146A (en)	1983-01-31	1987-03-10	Fujisawa Pharmaceutical Co., Ltd.	Thiazole derivatives and pharmaceutical composition comprising the same
DE3804531A1 (de)	1988-02-13	1989-08-24	Bayer Ag	5-cyano-2,4-diamino-thiazol-derivate
IE68593B1 (en)	1989-12-06	1996-06-26	Sanofi Sa	Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
US5620963A (en)	1991-10-15	1997-04-15	Isis Pharmaceuticals, Inc.	Oligonucleotides for modulating protein kinase C having phosphorothioate linkages of high chiral purity
US5721237A (en)	1991-05-10	1998-02-24	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
US5710158A (en) *	1991-05-10	1998-01-20	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5409930A (en)	1991-05-10	1995-04-25	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
ATE273386T1 (de)	1991-09-20	2004-08-15	Hutchinson Fred Cancer Res	Menschliches cyclin e
US5262409A (en)	1991-10-11	1993-11-16	Fred Hutchinson Cancer Research Center	Binary tumor therapy
US5441880A (en)	1991-11-18	1995-08-15	Cold Spring Harbor Laboratory	Human cdc25 genes, encoded products and uses thereof
US5302706A (en)	1991-12-16	1994-04-12	Baylor College Of Medicine	Senescent cell derived inhibitors of DNA synthesis
US5596079A (en)	1991-12-16	1997-01-21	Smith; James R.	Mimetics of senescent cell derived inhibitors of DNA synthesis
ES2268684T3 (es)	1992-04-10	2007-03-16	Dana-Farber Cancer Institute, Inc.	Inmunodeteccion de fosfoproteina especifica al estado de activacion.
WO1994007522A1 (en)	1992-09-30	1994-04-14	Yale University	Therapeutic and diagnostic methods and compositions based on transducin-like enhancer of split proteins and nucleic acids
US5543291A (en)	1993-01-29	1996-08-06	Dana Farber Cancer Institute	Method of detecting carcinoma
CA2162586C (en)	1993-05-13	2006-01-03	David J. Grainger	Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US5443962A (en)	1993-06-04	1995-08-22	Mitotix, Inc.	Methods of identifying inhibitors of cdc25 phosphatase
US5514571A (en)	1993-08-05	1996-05-07	University Technologies International Inc.	Cyclin D1 negative regulatory activity
US5473056A (en)	1993-10-13	1995-12-05	Merck & Co., Inc.	E2F-2, a novel mammalian transcription factor
US5532167A (en)	1994-01-07	1996-07-02	Beth Israel Hospital	Substrate specificity of protein kinases
US5484710A (en)	1994-01-14	1996-01-16	La Jolla Cancer Research Foundation	Method of down-regulating a gene linked to a P-53 responsive element
US5625031A (en)	1994-02-08	1997-04-29	Bristol-Myers Squibb Company	Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
CN1128049A (zh)	1994-03-18	1996-07-31	犹他大学研究基金会	多肿瘤抑制因子基因种系突变及检测该基因癌肿倾向性的方法
US5496831A (en)	1994-05-13	1996-03-05	The General Hospital Corporation	Inhibition of insulin-induced adiposis
US5631156A (en)	1994-06-21	1997-05-20	The University Of Michigan	DNA encoding and 18 KD CDK6 inhibiting protein
US5571523A (en)	1995-03-09	1996-11-05	President And Fellows Of Harvard College	Antioxidant-induced apoptosis in vascular smooth muscle cells
BR9611157A (pt)	1995-11-01	1999-03-30	Novartis Ag	Derivados de purina e processos para sua preparação
TW513418B (en)	1996-07-31	2002-12-11	Otsuka Pharma Co Ltd	Thiazole derivatives, their production and use
DZ2285A1 (fr)	1996-08-08	2002-12-25	Smithkline Beecham Corp	Inhibiteurs de protéase de la cystéine.
NZ503788A (en) *	1997-10-27	2002-11-26	Agouron Pharma	4-aminothiazole derivatives and their use as inhibitors of cyclin-dependent kinases
UA71971C2 (en) *	1999-06-04	2005-01-17	Agoron Pharmaceuticals Inc	Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases

1998
- 1998-10-27 NZ NZ503788A patent/NZ503788A/xx unknown
- 1998-10-27 AU AU13664/99A patent/AU738792B2/en not_active Ceased
- 1998-10-27 WO PCT/US1998/022809 patent/WO1999021845A2/en not_active Ceased
- 1998-10-27 SI SI9820068A patent/SI20324A/sl unknown
- 1998-10-27 AT AT98957393T patent/ATE315553T1/de not_active IP Right Cessation
- 1998-10-27 BR BR9815200-9A patent/BR9815200A/pt not_active Application Discontinuation
- 1998-10-27 DE DE69833223T patent/DE69833223T2/de not_active Expired - Fee Related
- 1998-10-27 EP EP98957393A patent/EP1056732B1/en not_active Expired - Lifetime
- 1998-10-27 PL PL98342447A patent/PL342447A1/xx not_active Application Discontinuation
- 1998-10-27 CN CNB988104741A patent/CN1158269C/zh not_active Expired - Fee Related
- 1998-10-27 JP JP2000517957A patent/JP2004500304A/ja active Pending
- 1998-10-27 US US09/179,744 patent/US6569878B1/en not_active Expired - Fee Related
- 1998-10-27 ES ES98957393T patent/ES2256968T3/es not_active Expired - Lifetime
- 1998-10-27 AT AT02001881T patent/ATE332896T1/de not_active IP Right Cessation
- 1998-10-27 TR TR2000/01081T patent/TR200001081T2/xx unknown
- 1998-10-27 YU YU22400A patent/YU22400A/sh unknown
- 1998-10-27 HR HR20000222A patent/HRP20000222A2/hr not_active Application Discontinuation
- 1998-10-27 IL IL13557498A patent/IL135574A0/xx unknown
- 1998-10-27 ES ES02001881T patent/ES2267873T3/es not_active Expired - Lifetime
- 1998-10-27 EA EA200000464A patent/EA003527B1/ru not_active IP Right Cessation
- 1998-10-27 ID IDW20000740A patent/ID24372A/id unknown
- 1998-10-27 KR KR1020007004392A patent/KR20010082501A/ko not_active Ceased
- 1998-10-27 SK SK521-2000A patent/SK5212000A3/sk unknown
- 1998-10-27 CA CA002306082A patent/CA2306082A1/en not_active Abandoned
- 1998-10-27 DE DE69835241T patent/DE69835241T2/de not_active Expired - Fee Related
- 1998-10-27 GE GEAP19985301A patent/GEP20032896B/en unknown
- 1998-10-27 AP APAP/P/2000/001795A patent/AP1445A/en active
- 1998-10-27 RO ROA200000423A patent/RO119463B1/ro unknown
- 1998-10-27 HU HU0004512A patent/HUP0004512A3/hu unknown
- 1998-10-27 EE EEP200000289A patent/EE200000289A/xx unknown
- 1998-10-27 UA UA2000042107A patent/UA66810C2/uk unknown
2000
- 2000-04-14 LT LT2000033A patent/LT4855B/lt not_active IP Right Cessation
- 2000-04-14 NO NO20001955A patent/NO20001955L/no not_active Application Discontinuation
- 2000-04-19 IS IS5462A patent/IS5462A/is unknown
- 2000-04-25 OA OA1200000120A patent/OA11352A/en unknown
- 2000-05-03 LV LVP-00-51A patent/LV12592B/en unknown
- 2000-05-26 BG BG104478A patent/BG64195B1/bg unknown
2003
- 2003-03-13 US US10/388,851 patent/US20030220326A1/en not_active Abandoned

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997016447A1 (en)	1995-10-31	1997-05-09	Mitotix, Inc.	Inhibitors of cyclin-dependent kinases
US5733920A (en)	1995-10-31	1998-03-31	Mitotix, Inc.	Inhibitors of cyclin dependent kinases
WO1997042949A1 (en)	1996-05-10	1997-11-20	Bristol-Myers Squibb Company	2-thio or 2-oxo flavopiridol analogs
WO1998017662A1 (en)	1996-10-18	1998-04-30	Novartis Ag	Phenyl-substituted bicyclic heterocyclyl derivatives and their use
WO1998033798A2 (en)	1997-02-05	1998-08-06	Warner Lambert Company	Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
HARPER: "Cyclin dependent Kinase Inhibitors", CANCER SURV., 1997, pages 91 - 107
KAMB ET AL.: "A cell Cycle Regulator Potentially involved in Genesis of Many Tumor Types", SCIENCE, 1994, pages 436 - 440, XP001055295, DOI: doi:10.1126/science.8153634
LODA ET AL.: "Increased proteosome-dependent Degradation of Cyclin-dependent Kinase Inhibitor p27 in Agressive Colorectal Carcinomas", NATURE MEDICINE, 1997, pages 231 - 234
LUKAS ET AL.: "Cyclin E-induced S Phase Without Activation of the pRb/E2F Pathway", GENES AND DEV., 1997, pages 1479 - 1492
NASMYTH, K.: "Viewpoint: Putting the Cell Cycle in Order", SCIENCE, 1996, pages 1643 - 1677
NOBORI ET AL.: "Deletions of the Cyclin Dependent Kinase-4 Inhibitor Gene in Multiple Human Cancers", NATURE, 1994, pages 753 - 756, XP002069794, DOI: doi:10.1038/368753a0

Also Published As

Publication number	Publication date
CN1158269C (zh)	2004-07-21
EA200000464A1 (ru)	2000-12-25
TR200001081T2 (tr)	2000-10-23
EE200000289A (et)	2001-06-15
HUP0004512A2 (hu)	2002-03-28
BR9815200A (pt)	2001-10-16
WO1999021845A2 (en)	1999-05-06
ES2267873T3 (es)	2007-03-16
GEP20032896B (en)	2003-02-25
DE69833223T2 (de)	2006-09-14
EA003527B1 (ru)	2003-06-26
UA66810C2 (uk)	2004-06-15
ES2256968T3 (es)	2006-07-16
HRP20000222A2 (en)	2001-02-28
SK5212000A3 (en)	2001-04-09
IL135574A0 (en)	2001-05-20
LV12592B (en)	2001-07-20
SI20324A (sl)	2001-02-28
NZ503788A (en)	2002-11-26
DE69835241D1 (de)	2006-08-24
DE69833223D1 (de)	2006-04-06
HUP0004512A3 (en)	2003-01-28
AU738792B2 (en)	2001-09-27
RO119463B1 (ro)	2004-11-30
KR20010082501A (ko)	2001-08-30
LT2000033A (en)	2001-06-25
BG64195B1 (bg)	2004-04-30
US20030220326A1 (en)	2003-11-27
LV12592A (en)	2000-12-20
US6569878B1 (en)	2003-05-27
EP1056732A2 (en)	2000-12-06
ATE315553T1 (de)	2006-02-15
ID24372A (id)	2000-07-13
CN1276789A (zh)	2000-12-13
NO20001955D0 (no)	2000-04-14
CA2306082A1 (en)	1999-05-06
OA11352A (en)	2003-12-23
DE69835241T2 (de)	2007-05-31
AP2000001795A0 (en)	2000-06-30
JP2004500304A (ja)	2004-01-08
BG104478A (en)	2001-02-28
AP1445A (en)	2005-07-10
IS5462A (is)	2000-04-19
EP1056732B1 (en)	2006-01-11
NO20001955L (no)	2000-06-16
PL342447A1 (en)	2001-06-04
YU22400A (sh)	2003-08-29
WO1999021845A3 (en)	1999-08-19
AU1366499A (en)	1999-05-17
ATE332896T1 (de)	2006-08-15

Legal Events

Date	Code	Title	Description
2007-06-26	MM9A	Lapsed patents	Effective date: 20061027

Publication	Publication Date	Title
LT4855B (lt)	2001-11-26	Pakeisti 4-amino-tiazol-2-il junginiai kaip nuo ciklino priklausomų kinazių inhibitoriai
AU2002353718B2 (en)	2007-05-10	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
ES2358863T3 (es)	2011-05-16	Hetarilanilinas como moduladores de beta-amiloide.
SK17302001A3 (sk)	2004-01-08	Tiazolové zlúčeniny a farmaceutické zmesi na inhibíciu proteínkináz a na metódy ich využívania
CA2659155A1 (en)	2008-01-24	Substituted azole aromatic heterocycles as inhibitors of 11.beta.-hsd-1
EP2637658A1 (en)	2013-09-18	Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
NZ522538A (en)	2004-09-24	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 their use and preparation
CA2452609A1 (en)	2003-01-16	Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use
JP2005508931A (ja)	2005-04-07	抗増殖性化合物としてのｎ−（４−（４−メチルチアゾール−５−イル）ピリミジン−２−イル）−ｎ−フェニルアミン類
US6566363B2 (en)	2003-05-20	Pyrazole-thiazole compounds, pharmaceutical compositions containing them
EP1215208A2 (en)	2002-06-19	4-Aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
NZ517419A (en)	2003-08-29	4-aminothiazole derivatives and their use as inhibitors of cyclin-dependent kinases
MXPA00003812A (en)	2001-05-07	4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
CZ20001285A3 (cs)	2001-01-17	Substituované 4-aminothiazol-2-ylové sloučeniny jako inhibitory cyklin-dependentních kinas
AU2007205749A1 (en)	2007-08-30	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1